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ABSTRACT 
Part I 
Attempts to obtain a substance with Rh antigenic 
activity from human red blood cells are described. At 
first, some extractions of the cells using ethanol, 
methanol, acetone, ether, dioxan, chloroform, and tol-
uene, under different conditions, were performed. 
Later work involved treatment of the cells with aqueous 
reagents to degrade the cell wall, followed by attempts 
to obtain a purified, active extract by precipitation 
or solution. None of these methods yielded a pure, 
specifically active Rh antigenic material. 
Part II 
The fractionation of an anti-Rh serum by electro-
phoresis-convection, and the immunologic characterization 
of these fractions, are described. Evidence is 
presented to show that certain anti-Rh antibodies may 
exist in globulin fractions other than the -; -globulin. 
Part III 
Experiments are described in which the vasocon-
s tr icting actions of adrenaline and of nor-adrenaline 
on rats were compared. It was concluded that there was 
but little difference in their action in this respect. 
Other experiments indicated that the administration of 
these drugs to lightly anaesthetized rabbits did not 
affect the metabolic rate of the sub j ects. 
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PART I 
ATT1'MPTS TO I SOLA TE 'I'HE Rh Al\fTIGEN FROM RED BLOOD CELLS 
-1-
INTRODUCTION 
In 1940, Lana.steiner ana Wiener (l} shcwea. that when a 
rabbit wa:s injectea. with rhesus monkey erythrocytes, its 
serum agglutinated the red blood cells of certain humans. 
This indicated that there was some relationship between the 
rhesus monkey erythrocyte ana. human erythrocytes, and led to 
the identification of a new speciric blooa. !'actor, which was 
called by these workers the Rh 1·actor. About the same time, 
Levine and Stetson (2) ana. Wiener and Peters (3} a.escribed 
an agglutination reaction between a rew human serums and the 
red blooa. cells of certain individuals; this reaction bore 
no apparent relationship to those or the ordinary specific 
blood types. It was recognized shortly thereafter that the 
Rh factor was the antigen which was ultimately responsible 
{through the production of specific antibodies) for both of 
the above agglutination reactions. Subsequent work showed 
that approximately 85% of white Caucasians had erythrocytes 
which were agglutinated by these few human serums - i.e. they 
were "Rh positive." The cells of the remaining 15% were not 
agglutinated, and they were therefore "Rh negative." Several 
different antigenic Rh components are now recognized, and 
these give rise to many subgroups and combinations of subgroups. 
This antigen has been found to occur mainly in the ery-
throcyte. Small amounts have been found in human saliva 
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(Wiener and Forer, 4), in s ome organs of the body (Boorman 
and Dodd, 5) and in the amniotic fluid of some Rh positive 
infants (Witebsky and Mohn, 6) . 
One of the chief distinctions between the Rh antigen 
and the classical blood type antigen lies in the nature of 
their specific antibodies. Normally Rh negative individuals 
do not have circulating anti-Rh antibodies; these are only 
built up as a result of an immunization with an Rh antigen. 
In contrast, persons with type A blood cells normally have 
anti-B antibodies in their serum; persons with type B cells 
have anti-A antibodies, and those of type 0 contain anti-
bodies for both A and B antigens. The existence of these 
specific antibodies does not re quire an antigenic stimulus, 
but is instead a result of an inherited condition. 
When the present research program to isolate the Rh 
antigenic factor was begun, but few attempts had been made 
to isolate this material. From some preliminary studies , 
Wiener believed that the 'material was soluble in alcohol, 
and hence was lipid in nature. Campbell and Fisk (unpub-
lished) also concluded from some preliminary experiments 
that the material was of lipid nature, but were unable to 
obtain reproducible results. Calvin et al (7) were able to 
isolate a large molecular vveight material which was fairly 
soluble in ·water. 'rhe following is a brief resume of their 
investigation: 
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To one volume of pooled red blood cells there were 
added eight volumes of' distilled water at 5°c. The pH of' 
the hemolysed cells was adjusted to 5.5 - 6.0, and the pre-
cipitated stroma were washed at this pH to remove the hemo-
globin. A cloudy solution was formed from the stroma when 
the pH was adjusted to 7 - 8. Centrifuging at 50,000 G 
yielded a precipitate which was called "elenin''. This dis-
solved at pH 7.5 - 8.0 to give a milky solution, with 
marked streaming birefringence. 
The elenin lost its immunological specificity after being 
heated to 56°c. for five minutes . Electrophoresis of a 0.1% 
elenin solution, at 2°c., in phosphate buffer at pH 7.8 and 
ionic strength 0.2, showed two components: 
1. About 80% of the material had a mobility of 6 x lo-5 
cm. 2/v . /sec . 
2 . gbout 15% of the material had a mobility of 8 x lo-5 
cm. 2/v./sec. 
From elenin, about 40%- 50% of lipid material could be 
extracted by an alcohol- ether mixture. In some cases, an 
ether soluble material which would. give an indication of Rh 
activity was obtained. Thi s material was thermostable for 
60 minutes at 56°c. 
Elenin solutions from Rh positive cells showed good 
s .pecif ic Rh activity as judged by agglutination inhibition 
tests. However, no specific anti-Rh antibodies could be 
built up by elenin injection into guinea pigs or rabbits . 
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Injection of this material into human subjects failed 
to increase any existing antibody titer. Intramuscular 
injection of large quantities (1 to 1.5 grams} failed to 
effect a change in the titer of the circulating antibodies. 
Perhaps the greatest amount of interest has been cen-
tered on Carter's investigations (8,9). The material which 
she isolated had lipid properties, and was obtained in the 
following way: 
Pooled cells were lysed by the addition of half a 
volume of r.' ater, and then 5 volumes of 95% ethanol were 
added. The mixture was allowed to stand in the cold over-
night. the alcoholic solution was then filtered off and the 
reddish residue was dried in air. This product was washed 
twice with aqueous alcohol solutions, and re-dried. Five 
volumes of ether were added and extraction was allowed te 
continue in the cold for periods of' up to 5 days. Separation 
and evaporation of the ether extract yielded a yellowish, 
waxy residue which was soluble in alcohol. This was claimed 
to be active in complement fixation tests, in agglutination 
inhibition reactions, in the production of antibodies in 
guinea pigs when used with a carrier, and in neutralization 
of antibodies in vivo. 
Price et al (10) have reported a purification of 
Carter's alcohol soluble material. Phospholipids were re-
moved from an ether solution of the crude materi al by a 
precipitation with acetone. The soluble portion was 
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chromatographed from pentane saturated with 95% methanol, 
on a silica gel column. Fractionation and re-crystalliza-
tion i'rom ether-pentane or chloroform-pentane yielded 
glistening needles, with a melting point of 156.9° - i57.2°c. 
The material was soluble in alkali, but precipitated 
upon the addition of co2 • It had a neutral equivalent of 
230 ±5, and a pK of l0±0 .5. It gave no color with f erric 
chloride, it sublimed unchanged, and it was recovered un-
changed after boiling for 1 hour with alcoholic alkali, 
after refluxing with pyridine-acetic anhydride and after 
treatment with semicarbazide acetate for 2 days. Analysis 
showed 58.J9% of carbon and 7.79% of hydrogen. This frac-
tion showed a high compleme nt-fixing activity vd th anti-Rh 
serum. However, since no study was made of' similar products 
from Rh negative cells, no conclusions may be made as to 
the specificity of the product. 
On the other hand, extracts prepared according to 
Carter's directions in other laboratories (Wiener, 11: 
Howe and Rustigian, 12} have not shown any specific acti-
vity, as judged by agglutination inhibition tests, comple-
ment fixation tests, and attempts at antibody formation. 
Spielman (13 ) has also claimed to have isolated a sub-
stance with specific activity. Rh positive erythrocytes 
were extractea i'or 8 days at 37°c. with 5 volumes of ethanol. 
The al coholic filtrate v;as evaporated to dryness at 25°c. 
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in a vacuum, and was then suspended in 1;.;ater and extracted 
with ether. The ethereal extract was washed with dilute 
acid and water, and finally dried with Na2so4. It was con-
centrated by evaporation and a precipitate was obtained by 
the addition of acetone. A cyclohexane solution of this 
precipitate was passed through an aluminum oxide column, 
and a zone which contained inactive materials was noted. 
This part of the column was discarded; the rest was re-
fluxed with ethanol, and a final product consisting of a 
light brown, s ticky , sometimes waxy material vms obtained. 
Activity in agglutionation i nhibition tests, in complement 
fixation tests and in antibody neutralization tests in 
guinea pigs was claimed. However , identical extracts made 
from negative cells gave s imilar results, so it is very 
questionable whether a specific substance has been extracted 
by this procedure. 
A water-soluble material which exhibited some Rh acti-
vity , as judged by agglutination inhibit i on reactions , has 
been found in the amniotic fluid of certain Rh positive 
infants by Mohn and VVi tebsky (6) . ·rhey attempted , unsuccess-
fully , to purify the substance by precipitation with alcohol , 
acetone and other agents which were not specified , and there-
fore concluded that the specific factor was very sensitive 
to the action of such agents . The material was , however , 
stable to lyophilization . 
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Chemistry of the A and B Factors: The Rh factor is at 
least morphologically related to the A and B factors, and 
it is therefore of interest to consider briefly some chemi-
cal aspects of these latter, better-known factors. Like 
the Rh factor, the A and B factors are found on the ery-
throcyte. However, in marked contrast to the Rh factor, 
substances which show A and B activity are found in some 
body fluids and organs in large quantities and in a readily 
extractable form. It is from such sources (notably hog 
stomach and the gastric juice of certain appropriate indi-
viduals) that most of the material which has been studied 
has been obtained. It should be noted that the substances 
wLich are not obtained from the erythrocyte are not 
necessarily the same as the material which is on the ery-
throcyte, but there must be some very close antigenic rela-
tionship. 
Hallauer (14) obtained material with A and B specific 
activity by alcoholic extraction or erythrocytes, and later 
Kosjakow and Tribulev (15) reported. a similar extraction o:t' 
a specific material, with a subsequent purification through 
the removal of protein material by precipitation with tri-
chloracetic acict. 
Witebsky ana Klenashoj (16), by means of alcoholic 
precipitation in the presence of soctium acetate, and subse-
quent aeproteinization, were able to obtain group speciric 
substances from certain gastric juices. 
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Morgan and. King (17) obtained. a water-soluble A sub-
stance rrom hog gastric mucin by precipitation with sodium 
sulfate. They were also able to dissolve the A substance 
in mucin with 90% phenol. A precipitation wi th ethanol and 
1'urther purification yielded. an immunologically active 
product. 
From all these d.irrerent sources, the materials prepered 
by various workers have fairly constant pr operties. The 
composition 01· A substance is about as follows: 
c 44.6% - 47.2% Acety.L group 9 . 4% - 12 . 1% 
H 6.5% - 6. 9% Hexosarnine 21.5% - 38.6% 
N 5.5% - 7.1% Reducing 45% - 84% 
substance 
Ash 0% 2.4~~ (calculated as glucose } 
D-galactose ano. N-acetyl D-glucosamine have been identified., 
and in some extracts L-i'ucose has been round. . 'rhe presence 
or D-mannose is uncertain. Numerous amino acieis have been 
found. 
The acetyl group is apparently necessary f or A sub-
stance a c tivity. If t h is group is removed , activity is 
lost, but can be restored by acetylation. Some of the 
products have been f ound to be uns table to alkali. One 
preparation derived f'rom hog stomach was serologically 
stable 1'or two days at 37°0. between pH 1.07 and. l0.7. At 
higher temperatures, the pH range over which the substance 
was stable narrowed, but the extract al ways showed a greater 
sensitivity to denatura tion by base. 
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The general conclusion is that the A and B factors 
are rather similar to each other in their chemical nature, 
and that the haptenic groups are probably polysaccharides. 
A molecular weight of about 70,000 has been estimated for 
the specific A substance from hog gastric mucih. Some 
amino acid structures are also present, and they may play 
an important part in the serological specificity of these 
group specific substances (Landsteiner and Harte, 18). The 
A substance has been shown to be i mmunologically related 
to the alcohol-soluble Forssman hapten. 
Practically nothing is known of the chemical nature 
of s ome of the other blood factors, such as the M, N, S 
factors, the Kell factor, or the P, Lewis, or Lutheran 
factors. 
The work to be reported describes some attempts to 
extract the Rh anti gen and to investigate some of its 
chemical and serological properties. In the first series 
of experiments , Rh positive, type 0 erythrocytes were 
treated ~ith s ome different organic solvents, and the 
material which was extracted was tested for .s.c tivity. In 
no cases could a specific Rh activity be demonstrated. 
A second series of experiments was performed in which 
some fractionation of the s troma of the red cell with 
aqueous reagents was ate.empted. While some breakd..ovm of 
the cell wall was apparently achieved, no satisfactory 
fractionation of the protein which comprises this wall 
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could be obtained. By using the partly degraded material, 
the stability of the Rh site to some denaturation agents 
was studied, and some attempts were made to obta in specific 
an ti-Rh antibodies in animals. 
EXPERI MENTAL 
~a terials and Methoas 
Red Blood Cells. Red blood cells were required for two 
procedures in this study; they were a source of the Rh 
antigen, and they were used in the serological tests. 
Those cells used f or the antigen source were Rh posi-
tive, type 0 erythrocyte s wh ich had been obtained from 
Hyland Laboratories.* In most cases, from three to six 
samples of blood vvere pooled for the extraction. These 
cells were usually t hree to tour days old when the experi-
ment was started; in a few cases they were only a day old. 
Extra ctions were generally done on Rh positive cells 
only. If a preliminary test indic a ted any degree of acti-
vity in the product, another preparation was prepared from 
Rh negative cells in the same -,my . Pa r allel tests we re 
then run on the tvvo samples. 
Red blood cells whi ch were used for the serological 
tes ting were usually obt a ined from the Pasadena Clinical 
Laboratory.*'i< From one to four samples of Rh positive, 
* 4534 W. Suns et Blvd., Los Ange les. 
** 65 N. ~adison Ave., Pasadena . 
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type 0 cells which were less than two days old were pooled 
and were washed three to four times with 0.9% saline. They 
were then mad.e up to a 2% - 5i~ (by volume) suspension in 
saline. 
Anti-Rh serum for serological tests. Most of the antiserums 
used for the tests were supplied by Dr. S. Haberman, of the 
William Buchanan Blood Center, Ba/ lor Hospital, Dallas, 
Texas. These anti-serums caused agglutination of appro-
priate cells in a saline medium, and were of the type Rh 0 
or Rh'. 
0 
.An anti-serum of type Rh0 agglutinates the red cells of 
85% of white Caucasians, and it is on the basis of this ag-
glutination test that a person is classified as clinically 
"Rh positivetf or clinically "Rh negativet'. Some serums can 
also agglutinate the cells of an additional 1% of white 
Caucasians. The cells are not agglutinated by the anti-Rh0 
f 
serum, and are classified as Rh • Most of the anti-serwns 
which agglutinate Rh' cells also shovv Rh0 activity; they are 
therefore classified as anti-Rh~ serums. 
These anti-serums are all from human sources. The pro-
duction of Rh antiserums in animals is found to be very 
unsatisfactory, since high anti-Rh titers cannot be pro-
duced, and the specificity of the action of the antibodies 
is uncertain. 
Serological Tests. The activities of the preparations were 
tested by means of the agglutination inhibition test. 
-12-
.An agglutinating ant i-Rh serum was diluted with 0.9% 
saline so that a series of final concentrations ranging 
from 1/5 to 1/160 of the original antiserum strength was 
obtained. To a series of test tubes there were added 0.02 
milliliters of each of these dilutions, as well as 0.02 
milliliters of the antigenic material which was to be 
tested. A similar series of antiserum dilutions was set 
up and 0.02 milliliters of a control material were added. 
The mixture wa s incubated at 37°c. for JO minutes, and 
then the erythrocyte suspension was added. Incubation 
was continued for 10 minutes at 37°c., and for 20 minutes 
at 27°c . Tl1e tubes were then lightly centrifuged , and 
examined to s ee if agglutination of the test red cells had 
occurred. Usually the test tubes were re-centrifuged and 
re-examined, and in doubtful cases a microscopic check was 
made to determine the agglutination. The results of a 
typical test are shown in Table I. It is seen that added 
specific antigen has combined with some of the antibody 
and thus effectively weakened the antiserum - i.e. there 
has been inhibition. 
The stock antigen solution for the lipid antigen was 
usually prepared by adding 1 volume of a saturated alco-
holic solution of the antigen to 2 volumes of 0 . 9% saline 
at 37°c. In cases where the procedure was di.fferent, the 
method whi ch was followed is outlined in the explanatory 
notes . In preliminary tests, controls consisted of a 
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solution of 1 part of ethanol to 2 parts of saline. As 
previously indicated, controls were also run in which 
lipid extracts of Rh negative cells were used . 
VJhen aqueous suspensions of' an antigenic material were 
obt a ined, they were used without further treatment. Con-
trol experiments used 0 . 9% saline, isotonic buf fers , or a 
preparation from Rh negative cells. 
Antigen 
From Rh 
From Rh 
Saline 
+-t+ 
Table I 
Agglutination Tests with Added Antigen 
Antiserum Dilutions 
Added 1:5 1:10 1:20 1:40 1:80 1:160 
positive cells ~+ '!' ·H + 
negative cells +"" . .~ +++ ++ ;.+ + 
-!-++ +++ ++ ++ + + 
Strong agglutination - f e-vv large clumps of cells 
upon shaking 
Medium agglutination - several small clumps 
upon shaking 
Slight agglutina tion - many small clumps upon 
shaking 
Trac.:e of agglutination - small clumps , barely 
visible 
No agglutination - no visible clumps. 
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Organic Solvent Extracts 
Ethanol. After considerable preliminary work on extractive 
procedures, a series of ethanol extractions was performed. 
Different ratios of amounts of solvent to the amounts of 
cells were used, as well a s different conditions with respect 
to initial lysis, buffers, pH, added enzymes, or re-extrac-
tion wi th another solvent. These conditions are summarized 
in Table II. 'Tue explanatory notes which f ollow the table 
give more complete details about the procedure used, and on 
the different conditions of the experiment. The number on 
the first colwnn of' Table II corresponds to the number 
which designates the experiment in the added notes. All 
extractions were performed at 5°c. - s0 c. 
The measured yields of the ethanol extract varied from 
1. 8 to 8. 2 grams per liter of' packed cells. If this value 
is divided by a factor e qus l to the ratio of the volume of 
alcohol used to the volume of packed cells, a corrected 
value of from 1.1 grams per liter per unit volume ratio to 
1.8 grams per liter per unit volume ratio is obtained . 
The yields 01· the ether extracts which were obtained 
after the ethanol treatment varied from 1.2 grams per liter 
of cells to J.l grarris per liter of cells. The values , ad-
justed to the volume 01· ether used, varied from O. 2 grams 
per liter per unit volume ratio to 0.8 grams per liter per 
unit volume ratio. 
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Preparation 1. To 1500 milliliters or cells there were 
added with stirring 1500 milliliters 01· ethan ol. The mix-
ture stood 9 days and was then filtered.. Five liters of 
ether were added to the residue and extraction proceeded 
~or 18 days. The alc oholic extract gave slight activity 
in one test, and none in another. In two separate tests, 
the ether extract gave no activity. 
Preparation 2. Fifty milliliters or red blood. cells were 
shaken with 100 milliliters or cold. ethanol, and. the mix-
ture v.;as set aside a t 5°c. for 2 days. 'rhe alcoholic solu-
tion was t ak en orr and lyophilized , and. the dry product 
was suspended in 1 ml. oi' 0. 91~ saline. This stock was usea. 
for the inhibition tests. Very erratic results were obtained 
in all tests. 
Preparation 3. Following the work of Carter (8,9}, 1 liter 
or cells was acLCied to 5 liters 01· ethanol , the y1hole was 
stirred f or 2 hours and then allowed to stand overnight. 
The yellowish 1'il trate was removed and the solvent vms 
evaporated under vacuum, with tem.p eratur·es up to 31°c. 
The residue from the alcohol extraction was washed with an 
alcohol-ether mixture, and then re-extracted with 5 liters 
of ether. After 13 days in the cold., with occasional 
stirring , the ether supernatant was removed and evaporated, 
with temperatures up to 37°c. For testing, the extracts 
were dissolved in alcohol , and the s olution was added to an 
e qual volume of saline, as in Carter's procedure. In this 
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experiment, the alcohol extract gave slight signs of acti-
vity, while the ether extract gave no such indication . 
Preparation 4. An intermediate alkali treatment was then 
introduced into the extraction. Twenty milliliters of red 
cells were added to 100 milliliters of ethanol, and the mix-
ture was allowed to stand for 6 days in the cold. The sol-
vent was filtered off, the residue was partly dried in air , 
and then s haken with 100 milliliters of 0 . 03 N KOH. After 
4 days in the cold , 100 milliliters of ether were a dded, 
and the mixture was allowed to stand. for 7 days . 'rhe super-
natant gave a slight activity in one test. The alcohol ex-
tract gave slight activity in one test, and none in two 
other tests. 
Preparation 5. To 100 milliliters of cells there were added 
with shaking 500 milliliters of ethanol. The whole was 
stirred at 5°c. overnight . The solvent was then filtered. 
off, and the precipitate washed first with 600 milliliters 
of 50% (by volume} of ethanol in water, and then with 600 
milliliters of 25% (by volume} of ethanol in water. The 
washed precipitate was partially air dried, and then 600 
milliliters of ether were added. Extraction proceeded for 
4 days , after which the ether solution was removed and 
evaporated in a current of air. The precipitate was re-
extracted with 300 milliliters of ether for 5 days, and then 
the ethereal solution was removed and evaporated. Nei ther 
extract gave an indic at ion of specific activity. 
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Preparation 6. A s eri es of extracts of whole cells with 
ethanol was me.de. One hundred milliliters of cells were 
extracted with 500 milliliters of ethanol, in the cold , for 
3 days. The residue was divided into seven portions of 
approximately 15 grams each, and 45 milliliters of one of 
the follovving sol vents were a dded to each portion: (a) 
methanol, (b) ethanol, (c) ether, (d} acetone, (e) chloro-
form, ( f) toluene, ( g) dioxan. Extraction proceeded for 
at least 22 days at 5°c. when the solvents were filtered 
off', evaporated .'..' t room temp erature, and tested for acti-
vity. None of them. s hov: ed the presence of an Rh factor. 
Preparation ?. One hundred milliliters of cells were lysed 
by the addition of 100 milliliters of water, and 200 milli-
liters of ethanol were t hen added. The mixture was shaken 
and s t ored in the cold. After filtration, the residue vva s 
re-extracted with ether, to give a f il tra te which ·was eva-
porated to dryness and suspended in saline for testing. 
No consistent results coulu be obtained. The f i ltrate 
from the alcohol tre at ment was t reat ed with an equal volume 
of acetone, to yield a white precipitate. This was washed, 
susp ended in saline, and tested. No activity was found. 
Preparation 8. Ei ght hundred fifty milliliters of cells 
were lysed by the addition of 500 milliliters of' water, 
and then three liters of ethanol were slowly a dded, with 
shaking. After storage in the cold for 12 days, the mixture 
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was filtered, and the alcoholic filtrate evaporated to 
dryness, with tempera tures u.p to 50°c. The residue from 
the orig inal alcohol extraction was re-extracted with 4 
liters of ether for 36 days in the cold. The ethereal ex-
tract was evaporated to dryness at temperatures up to 6J 0 c. 
The alcohol extract gave no activity , whereas the ether 
extra ct gave only a weak indication . 
Preparation 9. One and one half liters of cells were lysed 
by the addition of' an e qual volume of water , and the whole 
poured into 5 liters of ethanol. 'rhis was done at room 
temperature . After 24 ho urs in the cold the precipitate 
was removed , partly dried , and stored at 5°c . for 6 days . 
Four and one half liters of ether were a dded, and the mix-
ture was stirred for J days, when the ether extract was fil -
tered of f . Both extr acts were evaporated to dryness. The 
maximum temperature r eached by the alcohol extract was 
27°0., that of the ether extract 8°C. The ether extract 
showed a s light activity. 
Carter had stated that the ether extract, if dissolved 
in alcohol and then poured into saline , gave a cloudy sus-
pension , from which a clear, active supernatant could be 
obtained upon centrifugation. The ether extract of this 
product was so treated, but no indic ation of activity could 
be obtained from the clear supernatant. 
Preparation 10. One liter of cells was lysed with l liter 
of water , and this was a dded , in t wo ba tches, over a period 
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of 3 days, to 5 liters of ethanol. The mixture was allowed 
to stand in the cold for 5 days, and then the precipitate 
was removed. The filtrate was evaporated to dryness, with 
tempe r ::' tures at a maximum of 32°c. To the precipi ts.te v.:as 
added 4~ liters of ether, and the extraction was allowed to 
proceed in the cold for 20 days . The ether solution was 
removed, evaporated, and tested. Neither extract gave any 
activity. 
Preparation 11. It is known that if Rh positive cells are 
treated suitably with trypsin , they are agglutinated much 
more readily by anti-Rh serums. 'rhe reason for this is not 
known, but it might be through an uncovering of additional 
sites on the cell surface, by the digestion and removal of 
somB sort of protein layer. In vi ew of thi s effect, it was 
decided to make some extractions using trypsin in the course 
of the preparation. Twenty milliliters of red cells were 
lysed with 100 milliliters of water, and 5 milliliters of 
a trypsin solution which contained 2 milligrams of trypsin* 
per milliliter were added. The mixture was allowed to 
stand at 37°c. for 15 minutes. One hundred fifty milli-
liters of ethanol were added and the mixture was put aside 
at 5°c. for 6 days. After filtration, the residue was 
a ir-dried as room temperature, and then 200 milliliters of 
ether were added. After 9 days of extraction in the cold 
the ether solution was removed and evaporated. The alcohol 
*Nutritional Biochemicals Corporation, 1-300. 
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extract gave an indication of activity in one test and no 
indic a tion in another. The ether extract showed slight 
activity . Experiments 17, 18 , 19, and 20 des cribe further 
exp eriments with trypsin treated cells. 
Preparation 12. To 10 milliliters of cells were adaed 50 
milliliters of ethanol, and. then suf ficient 0.1 N HCl or 
0.1 N NaOH was added to g ive pH values of 3.2, 5.8, 6.9, 
9.2. (The pH of the unaltered solution was measured at 
8.0.} .After 5 days in the cold, the mixtures were filtered , 
and the residues were air-dried. Fifty milliliters of 
ether were aad ed to each residue, and a r ter 14 days in the 
cold, the superna tants were removed. The ether extracts 
from the t wo most acid starting mixtures showed no activity, 
the material from the extraction at pH 6.9 showed a tre.ce of 
activity, and the las t extract showed no activity in one 
test and slight activity in another. 
Preparation 13. To 10 milliliters of cells and 50 milli-
liters of ethanol, there were added 10 milliliters of 
either 0.1 N KOH, 0.01 N KOH, water, 0.01 N HCl, or 0.1 
N HCl. The samples were shak en , stored 2 days at 5°c. and 
then 1'iltered. The residue iivas air-dried at room tempera-
ture, and 50 milliliters 01· ether here added. This mixture 
stood 2 days at 5°c. and the ether extra cts were removed 
and evapore ted. In s ev eral tests of these preparations, 
the neutral extract n ever showed any activity, while the 
others showed some slight activity . 
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Pre_paration 14. Another ex_p criment was r un in order to 
check the results or _prep arations 4 and 11. To 10 milli-
liters of cells and 50 milliliters of ethanol there were 
added, in diff'erent samples, 10 milliliters 01· water, 10 
mill iliters of _phosphate buffer of pH 7.43, 10 milliliters 
01· 0. 9% saline, 10 rnillili ters of 0 .1 N KOH, and 10 milli-
liters of 0 .1 N HCl. These 'vvere allowed. to stand for l day , 
and then the mixture was filtered. The _precipitate was 
washed in 20 milliliters of ether and to t he _precipitate 
was added 50 milliliters of dry, _peroxide-free ether. The 
mixture s tood 4 days a t 5°c., the ether solution was re-
moved, and the _precipitate vvas \1ashed with ether. Washing s 
were combined wi th the filtrates, and the whole evaporated. 
In this case, the burrer ed extrac t end the alkal i extract 
gave no activity, while the acid, saline, and water extracts 
gave a slight indication of activity. 
Preparation 15. In another run, there vvas acided to the 
alcohol-cells mixture, 50 milliliters of 0.01 N KOH in one 
case, and 10 milliliters or the same reagent in another 
case. After extraction f or a _period or 3 days at 5°c. the 
mixture was filtered and the residue was air-dried at room 
temperature. li'ii'ty mi lliliters 01· ether were then added 
and th e extraction continued tor another 14 days a t 5°c. 
The ether extracts gave no activity. 
Pre_paration 16. As a f urther test or the effect or pH upon 
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the extraction, a series of runs was performed in which 
10 milli l iters of red blood cells were added to 50 milli-
liters of ethanol, and then 20 milliliters of veronal buf-
fer were added, as well as sufricient 0.1 N HCl to give the 
following pH values: 3.1, 5.16, 6.11, 7.02, 7.J8. These 
extractions were allowed to stand for 6 days at 5°c. and 
were then filtered. To the residues were added 50 milli-
liters of ether. This extraction lasted 13 days at 5°c. 
Solvents were evaporated in a current of air, with the aid 
of an infra-red lamp. None of the alcoholic or ether ex-
tracts gave any inhibition. 
Prepa~ation 17. One hundred milliliters of cells were 
aaded to 100 milliliters of phosphate buffer, of pH 7.4. 
Ten milliliters of a 0.2% trypsin s olution were added. 
Thi s was incubated !'or 15 minutes at J7°C., then a total of 
500 milliliters of e thanol were adaed, with shaking, and the 
whole was then stored at 5°c. overnight. After filtration, 
the precipitate was first washed with 600 milliliters of 
50~b (by volume) of ethanol in water, and then with 600 
milliliters of 25% (by volume) of ethanol in water. The 
precipitate was partia l ly dried, and 600 milliliters of 
ether were added. Extraction proceeded for 4 days at 5°c. 
when the ether solution was removed and evaporated in a 
current of air. 'rhe precipitate ·was re-extracted with 300 
milliliters of ether for 5 days, and then this solution 
was evaporated. Neither extract gave any specific activity. 
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Preparation 18. The above experiment was repeated with a 
fresh batch of cells, but the second ether extraction was 
not performed. As a variation, a p arallel run was maae in 
which the trypsin was added directly to the cells, without 
the addition of buffer. Alcohol was added later, as above. 
Another parallel run, which actually duplicated the condi-
tions of one of the former runs (preparation 3), was made 
in which the trypsin and the buffer were both omitted, and 
alcohol was odeied airectly to the cells. This is described 
under preparation 5. No activity was found in any of the 
extracts. 
Preparation 19. In the course of another series of experi-
ments, the conditions of preparation 17 were set up, but 
with 1/10 the a.mounts of materials. The first ether extract 
was examined for activity, but none was found. 
Preparation 20. Two extractions were performed unaer the 
same initial conditions described for preparation 17 - i.e. 
to 1 volume of cells, plus 1 volume of phosphate buffer at 
pH 7.4, there was added 1/10 of a volume of trypsin solu-
tion. Incubation and extraction with 5 volumes of ethanol 
followed. In both cases, the alcoholic extract was inac-
tive. The precipitate \NBS extracted with 5 volumes of 
ethanol in one case, and in the other case with 5 volumes 
of an ethanol-ether mixture (ethanol:ether in volume ratio 
of 9:1). Neither extract was active. 
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Preparation 21. Five milliliters of cells were lysed in 
ice-cold water which had been saturated with carbon dioxide, 
and the resulting stroma were centrifuged of f as a heavy 
precipitate. They were washed three times with cold, co2-
saturated water, and then extracted at 5°c. for 1 day with 
25 milliliters of ethanol. The residue from the extraction 
was re-extracted with 25 milliliters of ether for 11 days. 
No activity was found in either of the extracts. 
Methanol. A small number of extractions were ma de in which 
methanol was the initial solvent. These experiments are 
summarized in Table III, and the corresponding notes follow 
the table. 
Table III 
Summary of Conditions of' Extraction with Methanol 
Preparation 
Number 
1 
2 
3 
Volume Ratios 
HzO:MeOH:Cells 
5 1 
1 5 1 
5 1 
Second 
Solvent 
ether 
ether 
methanol 
ethanol 
ether 
acetone 
dioxan 
Ratio of 
Volume Second Solvent 
Volume Cells 
5:1 
5:1 
See notes below 
chloroform 
toluene 
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Preparation 1. Ten milliliters of cells were mixed with 
50 milliliters of methanol, shaken, and extracted in the 
cold for 8 days. Thisyielded 0.07 grams of dried extract, 
or 1.4 grams per liter of cells per unit volume ratio. The 
first residue was re-extracted with 50 millilit ers of ether, 
to give another 0.03 grams of material, or 0.6 grams per 
liter of cells per unit volume ratio. Both extracts were 
inactive. 
Preparation 2. 'rhe experiment was later repeated using the 
same conditions as mentioned above, but in addition a 
parallel run was made in which the cells were first lysed by 
the addition of an e qual volume of water. In both cases, 
the ether extracts were inactive. 
Preparation J. One hundred milliliters of cells were shaken 
up with 500 milliliters of methanol and stored in the cold 
for 3 days. After the me thanol solution was removed, the 
residue was p artially air-dried, and divided into seven 
portions of about 15 grams each. Each portion was extracted 
with 45 milliliters of one of the seven solvents indicated, 
for at least 22 days. The residues obtained from the eva-
poration of the solvents were inactive. 
Acetone. The following notes summarize the two extractions 
in which acetone was the initial solvent. 
Preparation 1. Nine hundred milliliters of packed cells 
were extracted with 2 liters of a cetone in the cold for 4 
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days. The acetone extract was lyophilized, but gave no 
indica tion of activity. The residue from this first ex-
traction was re-extracted with five liters of ethanol in 
the cold for 26 days. This too yielded no activity after 
lyophilization. The yield of acetone extract was 2.1 grams, 
or 1.0 grams per liter of cells per unit volume ratio; 
that of the ethanol extract was J.4 grams, or 0.7 grams per 
liter of cells per unit volume ratio. 
Preparation 2. One hundred milliliters of cells were shaken 
up with 500 milliliters of acetone in the cold. Extraction 
proceeded for 3 days, when the acetone fraction was removed. 
The residue was air-dried and 45 milliliters of each of the 
seven different solvents as indic ated in the previous ex-
periments were added to 7-gram portions of dried residue. 
Extraction continued for a t least 22 days. No activity 
was obtained from any of the residues which resulted from 
the separation of the solution and evaporation of the 
solvent. 
Dioxan. Extractions with dioxan are indicated in 1rable IV 
and in the 6mplif ied notes. 
Preparation 1. Ten milliliters of cells were extracted 
with 50 milliliters of dioxan , in the cold for 10 days. 
The residue wa s re-extracted with 50 milliliters of ether 
for 2 months in the cold. The dioxan extract gave no 
activity , but the ether extract gave an apparent activity, 
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Table IV 
Swnrnary of Conditions of Extraction with Dioxan 
Preparation 
Number 
1 
2 
3 
Volume Ratios Second 
H20:Dioxan:Cells Solvent 
5 1 ether 
1 5 l ether 2 
5 1 methanol 
ethanol 
ether 
acetone 
dioxan 
Ratio of 
Volume Second Solvent 
Volume Cells 
5:1 
5:1 
See notes 
chloroform 
toluene 
which on the bas is of the results of the following experi-
ment was probably non-specific. The yield of the dioxan 
extract was 1.6 grams, or 32 grams per liter of ·cells per 
unit volume ratio; that of the ether extract was O.J grams, 
or 6 grams per liter of cells per unit volume ratio. 
Preparation 2. A second dioxan extract was made on 10 
milliliters of cells to which 5 milliliters of water had 
been added. Fifty milliliters of solvent were used, and 
extraction proceeded for 6 days in the cold. The solvent 
was f iltered off , and 50 milliliters of ether were added to 
the residue. The mixture was stored in the cold for 5 days, 
after which the ether solution was separated and the solvent 
evaporated. Neither extract gave any activity. 
Preparation 3. Following the procedure previously outlined, 
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100 milliliters of cells were extracted with 500 milliliters 
of dioxan for 3 days in the cold. The residue was divided 
into seven 1·ractions of approximately 15 grams each, for 
re-extraction with 45 milliliters of the seven solvents as 
in the former procedures. No activity was found in either 
the first extract or any of the subsequent re-extractions. 
Ether. MacFarlane (19) showed that lipoproteins could be 
extracted from serum proteins by a treatment at very low 
temperatures. This suggestion was followed, and these 
extractions were carried out. 
Preparation 1. Three milliliters of a stroma suspension 
were frozen in a dry ice-methyl cellosolve bath. To this, 
10 milli liters of ether which had been pre-cooled to under 
-20°c. were added. This was allowed to thaw slowly, and 
the ether layer was removed for evaporation and testing. 
Preparation 2. In a second experiment, an a ttempt was 
made to remove much of the water in the raw ma terial before 
the extraction with ether. Therefore the following pro-
cedure was undertaken. To 3 milliliters of suspension there 
were a dded 5 milliliters of chilled acetone. The mixture was 
quickly centrifuged, and the supernatant poured off. Ano-
ther washing with acetone INas quickly performed, and then 
10 milliliters of pre-cooled ether were added, the mixt ure 
thawed, the ether layer removed, and the solvent evaporated. 
No activity was obtained in either extract. 
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Preparation 3. According to Block (20 } lipoproteins may 
sometimes be extracted by successive treatments with ether, 
alcohol, and then ether again. 
To 10 milliliters of a stroma slurry, 50 milliliters 
of ether were added., with shaking . 'rhe whole stood l day 
in the refrigerator, when the ether was poured off , and 
another 50 milliliters of ether was added to t~e residue. 
Extraction was allowe d for l day in the cold, when the 
ether was taken oi'f and combined with the first ether ex-
tract. The residue was taken up with 50 milliliters of 
ethanol and extracted in the cold for 2 days. The ethanol 
extract was removed. The residue was washed with 5 mill i-
liters of ethanol, followed by two ether washings of 5 
milliliters each. Thirty milliliters of ether were then 
adei.ed, and after l day in the cold the supernatant was 
poured off and another 30 milliliters of ether were added. 
After a day for extraction, the ether layer was taken off 
and combined wi th the preceding ether solution. All extracts 
were evaporated to dryness and tested. None showed any 
activity. 
Ether-Alcohol. The above low- temp erature type of experiment 
was repeated, but dirrerent ether-alcohol mixtures were used 
for the solvent. In all cases, 5 milliliters of suspension 
were extracted wi th 20 milliliters of' sol vent . The experi-
ment was divided into t wo parts. In Part I, the stroma 
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samples were frozen and extracted with the different sol-
vents. In P e. rt II, the samples were vvashed twice, rapidly, 
with acetone, before the solvents were added. Temperatures 
in all cases were under -20°c. The different solvents were 
(a) 100% ether, (b) ether-alcohol (9:1 by volwne), (c} ether-
alcohol (5:5 by volume), (d ) ether-alcohol (1:9 by volume}, 
(el 100% alcohol. None of these extracts showed the 
slightest trace of activity. 
Phenol. An attemp t was msde to extract with phenol. 
Twenty milliliters of' stroma were mixed with 100 milliliters 
of phenol, and the mixture stored in the cold for 3 days. 
The total volume of the solution was 100 milliliters. Fifty 
milliliters were extracted with 3 portions of 25 milliliters 
each of phosphate buffer, pH 7. 36. 'rhe combined extracts 
were dialysed aga inst water, and then evaporated to con-
centrate them. No activity was found. 
Irnmunization Experiments. Some 2, ttempts were made to 
specifically i mmunize animals against the Rh factor, using 
organic solvent extracts as antigens. A carrier protein 
was injected along with the solution of the extract. No 
specific antibodies could be demonstrated. 
Experiment 1. One half gram of an extract which had given 
a weak indication of activity (see preparation 8 of the 
ethanol extractions} was dissolved in 75 milliliters of 
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ethanol at 56°0., and passed through a Sei tz filter. 
Seventy-five milliliters of saline were added through the 
filter. Eighty-two milliliters of a re-constituted sheep 
serum (8% dried serum in water) which had been Seitz filtered 
and centrifuged, were added to this, and the mixture stored 
in the cold. 
Six guinea pigs and 6 rabbits were injected with this 
antigen, over the course of two weeks. Rabbits received 4 
injections of 2 to 3 milliliters each, intrevenously, and 2 
injections of 2 to J milliliters intraperitoneally. The 
guinea pigs received 4 injections of 2 milliliters and 2 in-
jections of 1 milliliter, all intraperitoneally. At the 
end of th i s period, the guinea pigs hs d built up no titer, 
while the rs.bbi ts he. d d. eveloped agglutinins which were not 
specific for the Rh f actor. After a 12 day rest, the in-
jection of t h e guinea pigs was resumed, and over a period 
of a month they were g iven 10 injections of l mi~liliter 
each, intraperitoneally. Tney developed agglutinins to a 
titer of 256 against human red cells, but these were not 
specific for the Rh fac tor, as shovm by tests with both 
Rh positive and Rh negative cells. 
Experiment 2. A second series of injections was performed, 
with a different carrier protein and different conditions 
of conc entration and mixing. A stock extract solution was 
made by dissolving sufficient extract in c: lcohol to give a 
concentration of 0.5% by weight, and filtering this solution 
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through a Seitz filter. A serum solution was made by 
0 heating 35 milliliters of hog serum to 56 C. for 30 minutes, 
diluting with saline, and pas s ing through a Seitz filter. 
Boiled saline was added to bring the total volume to 360 
milliliters, and 4i milliliters of a 10% phenol solution 
were added as a preservative. 
The rabbits for the test were divided into four group s . 
of 3 animals each, and 6 intraperitoneal injections were 
given each animal during 2 weeks. 
Group I received 1 milligram of extract each. One 
volume of extract solution was mixed with 25 volumes of 
serwn solution , and after standing 1 hour, the proper volume 
to give the dose indicated was in ~ ected. The two solutions 
were mixed thus before eech injection. 
Group II received 1 milligram of extract. One volume 
of extract solution was mixed with 25 volumes of serum solu-
tion. The solutions were mixed at the beginning of the 
experiment, and this stock was used throughout for Group II. 
Group III received 10 milligrams of exGract. Ten 
volumes of extract solution were mixed with 25 volumes of 
serum solution, l hour before each injection, and then the 
proper amount was injected. 
Group IV received 10 milligrams of extract. The pro-
per amounts of extract solution and serum solution were 
mixed at the beginning of the experiment, and this stock 
was used throughout for Group IV injections. 
-35-
Two weeks after the l ast injection, the animals were 
bled. No specific agglutinins could be demonstrated in 
any of the sera. 
Conclusion. On the basis of agglutination inhibition tests, 
it appears that organic solvents will not extract the unde-
natured antigen from the erythrocyte. The failure of some 
attempts to develop specific agglutinins lends support to 
this statement. The significance of these results will be 
discussed later . 
Extracts from 'rrea tment with Aqueous Reagents 
Since the methods of extraction by organic solvents 
had not yielded an active product , some other methods of 
cell degradation and solution were tried. 
The Rh factor must be a structure on the surface of 
the cell wall, and any methods of cell solution must allow 
this complete site to pass into solution in some sort of 
undenatured form. This condition is presumably attained 
when A and B factors are extracted , but the evidence thus 
far is that the Rh site is not so readily removed in intact 
form. If it is a more or less integral part of the cell wall 
structure, and not something of the nature of a "side chain" 
on the cell wall, then a considerable breakdown of the red 
cell ghost will be necessary in order to put this structure 
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into solution. 
The main constituent of the cell wall is a protein 
which has been called stromatin. This has been recognized 
as a "protein sui generis" by Jorpes (21) on the basis of 
its amino &cid composi tion. Evidence shows that it is very 
difficult (short of drastic procedures) to put all or the 
cell wal l into solution. Mild treatment can rupture the 
wall, and apparently fragments of different sizes may be 
torn off. Some lipid constituents may be removed in the 
process of ordinary hemolysis; such material is ma inly neu-
tral fat and cholesterol esters (Ponder, 22). A globulin 
and an albumin are also reported to have been removed from 
the surface of t he cell wall with mild treatment (Ponder,23). 
Furchgott (24) tried to dissolve stroma in dilute 
alkali, but he could not obtain any satisfactory solution. 
He also tried, without success, dif1'erent concentrations of 
NaCl and KCl, in buffered phosphate. Follmving a procedure 
of Boehm (25) he treated lysed cells with 2.5 M LiClO buf-
4 
fered to pH 7. 8. The cell s ultimately broke into small 
fragments which he estimated to be 0.1 J.l in di ameter and 
1 )l long. 
Ballantine and Parpart (26) treated erythrocytes with 
trypsin at pH 6.8 for 24 hours, and found tha t there was 
no change in the permeability of the cell wall, as comp ared 
with normal cells. Presumably there had been but little 
degradation of the cell surface. On the other hand, 
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treatment with pancreatic lipase resulted in increased 
permeabil i ty , as measured by the susceptibility to hemo-
lysis . 
The work of Calvin and co-workers has already been 
mentioned (page 2, t his thesis}. Their elenin is presumably 
a lipo-protein fraction which is separable from stroma 
under the conditions mentioned. 
Stern et al (27) obtained stroma by freezing red blood 
cells. This product was suspended in a buffer, and then 
centrifuged. The supernatant solution showed two eledtro-
phoretic components (other than hemoglobin) and gave a good 
Tyndall effect. The slow component, which had approximately 
the same mobility as the slower of Calvin's components, was 
considered to have consisted of' particles of undegraded 
stroma. The faster component was not further identified. 
Sigurdson (28) claimed to have isolated small particles 
from stroma, after lysing the cells with hypotonic saline. 
Heating increased the degree of' breakdown. 
These results seem to indicate that in most cases there 
has been nothing more than a fragmentation of the cell vmll. 
Several large pieces are broken ofr, or the wall may be 
broken into comparatively l arge po1·tions, depending on the 
severity of the treatment. The smaller pieces are difficult 
to centri1'uge, and may be readily dispersed, probably to 
form a colloidal suspension. 
In undertaking the present work, it was thought that 
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a mild alkali treatment migh t break down some of the lipo-
protein complexes, and that some separa tion by salt frac-
tionation migh t then be achieved. Subse quently, other 
fractionation and extraction procedures, including some 
which had proved useful in the separation of bacterial an-
tigens, were applied to the product rrom the initial treat-
ment. No satisfactory further fra ct i onation was obtained. 
Preparation. Ten l!lillili ters of packed, Rh positive, type 
0 erythrocytes were mixed with 20 milliliters of 0.01 N KOH 
and the mixture was stored in the cold. Af ter 12 hours, 
no precipitate could be obtained after centrifuging at 
3,000 r.p.m. for 10 minutes. The pH ·was 7.2. Thirty milli-
liters of saturated ammonium sulrate (SAS) were added, and 
a flocculent precipitate was obtained. The pH was now 
about 6.4. The mixture stood 3 hours in the cold, and then 
the precipitate was centrifuged off and dialysed against 
water until no more sulfate was detectable in the dialysate. 
The precipitate was suspended in saline, and was found to 
g ive good inhibition of agglutination. Si milar material 
prepared from Rh negative cells gave no inhibition. This 
effect v.as checked a number of times, on different stocks 
of cells. 
Properties. In a rresh precipitate, the p&rticles were 
small enough and could be so readily dispersed in a saline 
or buffer solution that an active, cloudy supernatant was 
left after centrifuging the suspension for 10 minutes at 
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3,400 r.p.m. In old preparations or in one which had been 
suspended in water, a s imilar centrifuging gave a clear 
supernatant in which no activity could be detected . 
In Table V are shown the results of' an experiment in 
which an inhibitor sample was suspended in water (inhibitor 
A} or in phosphate buffer of pH 7. 4 (inhibitor B). The 
superna tant fr actions from a centrifugation as mentioned 
above were used for the test. 
Table V 
Activity Comparision of Different Inhibitor Suspensions 
Supernatant A 
Supernatant B 
Negative preparation 
Antiserum Concentration 
1/10 1/20 1/40 1/80 
++ 
+ ++ + 
There· was e suf1'icient excess of' antibody so that a 
prozone was beginning to show in the case of the most con-
centrated an tiserum . Inhibitor A, when it was later sus -
pended in saline , gave inhibition, thus showing that it had 
not been dena tured . With longer centrifuging, even in salin e 
suspension , the activity of the supernatant material decreased. 
A comp arison of the a ctivities of stroma, and of the 
preparation derived from stroma by the trea tment described , 
is shown in Table VI. Both the stroma and the preparation 
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derived from it were made from the same stock and were of 
the same age. App arently, the stroma has denatured more 
rapidly, or is less active, than the prepared material. 
The inhibitor material thus prepared, rather than stroma, 
was therefore used in subsequent tests. It will be referred 
to as the product of the KOH-SAS treatment. 
Table VI 
Comparison of Activities of Stroma and Preparation 
Stroma 
Positive cells 
Negative cells 
Preparation 
Positive cells 
Negative cells 
Antiserum Concentration 
1/ 40 1/80 1/160 Milligrams of· protein 
per milliliter 
++ 
......... .. . . 
++ 
+ 
2.8 
2.7 
4.7 
3.8 
Effect of pH Change. A number of 3 milliliter samples of 
a freshly prepared inhibitor wh ich had been checked for 
activity were adjusted to the pH values indica ted in the 
f ollovving table, with 0 .1 N KOH or 0 .1 N HCl. They were 
0 then heated for 1 hour at 37 C., and the pH was re-checked. 
All samples were brought to a pH of between 7.0 and 7.5 by 
addition of acid or base. In t wo of the samples, where but 
lit~le of the reagent ws s necessary to obtain neutrality, 
a small &mount of' salt solution was a6. cied to make a correction 
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for the volume change and ionic strength change which was 
attendant upon the neutralization of the other samples. 
'rable VII shows the pH values in the different phases of 
the test; Table VIII shows the results of the inhibition 
tests with the treated preparations. 
Table VII 
Conditions of Digestion 
Inhibitor Initial pH pH after digestion 
Sample 
5 4.72 4.68 
6 6.07 6.36 
7 7.14 7.25 
8 7.92 7.81 
8a 7.95 7.f:J5 
9 9.20 8.88 
9a 9.18 8.78 
10 9.96 9.51 
11 11.00 10.42 
* Add 1 milliliter 0.5% NaCl 
**Add ~milliliter 0 . 5% NaCl 
Adjust to pH 
7.01 
7.25 
7.18 
7.00 
7.20* 
7.18 
7.26** 
7.16 
7.42 
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Table VIII 
Agglutination with Treated Inhibitors 
Inhibitor Sample Antiserum Concentration 
1/10 1/20 1/40 1/80 
5 +++ -t-t+ ++ ++ 
6 ++ 
7 f 
8 :! 
8a 
9 + 
9a + 
10 +.a..a. .... + + 
11 , i'-!'-t ++ + + 
saline control +++ ++-t ........ .. + 
...... ..L strong agglutination of test erythrocytes ... 
~-!" medium agglutination of test erythrocytes 
+ slight agglutination of test erythrocytes 
+ trace of agglutination of test erythrocytes 
no agglutination of test erythrocytes 
The conclusion was that this extract had a maximum sta-
bility in the region of pH 8. There was an indication that 
at pH values 1 unit on either side of this, some denaturation 
occurred. 
An experiment to determine the rate of denaturation was 
set up. A sample of a preparation was suspended in buffer, 
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and heated to J7°C. Samples vvere removed at various times 
and used in agglutination inhibition tests. Similar extracts 
from Rh negative cells were used for controls. The decrease 
in the inhibitory activity of the preparation was followed, 
and thus a rough i dea of t h e extent of denaturation of the 
antigenic site was obtained. Precise measuremen ts were not 
po s sible, due to the inherent large error in the serial di-
lution techni que. However, it appeared that at pH 7.1, in 
phosphate bu1·fer, nearly all the activity was lost in 2 
hours. At pH 5.9, the activity was los t in JO minutes. 
Effect of Ethanol. The stability of the extract to ethanol 
was determined in the following way. Inhibitor stock was 
adaed to phosphate buffer, pH 7.34, and then different 
amounts of ethanol were added. Saline was added as 
necessary to bring samples to a definite volume. As a 
control, s i milar mixtures of . buffer, ethanol, and saline 
were made up, with ~ater a ti ded to take the place of the 
inhibitor. The actual constitution of the various solutions 
was as shown in Table IX. These solutions were heated for 
JO minutes at J7°C., and were then tested fo r a ctivity. 
The results are shown in Table X. In another run , a similar 
series was mbde up, with all reagents at s0 c. The inhibitor 
stocks stood with the alcohol in the cold overnight. Samples 
were then incubated with antiserum for l~ hours in the cold. 
Cell s were add ed, and the mixture kept in the cold for ano-
t her 40 minutes. The tubes were then centrifuged and read. 
The results of this test are shown in Table XI. 
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Table IX 
Composition of Inhibitor Suspensions 
Sample Volume of Phosphate Et OH Saline H 0 
(mf.) 
% EtOH 
Inhibitor Buff' er (ml.) (ml. ) 
Added pH 7.4 
(ml.} (ml.} 
i 1.5 1.0 0.50 0 
ii 1.5 1.0 0.05 0.45 1 
iii 1.5 1.0 0.10 0.40 2 
iv 1.5 1.0 0.25 0.25 6 
v 1.5 1.0 0.50 0.00 13 
vi 1.0 0.50 1.5 0 
vii 1.0 0.10 0.40 1.5 2 
viii 1.0 0.25 0.25 1.5 6 
ix 1.0 0.50 1.5 13 
Table X 
Agglutination with Treated Inhibitors 
Ethanol % 
0 Inhibitor i 
Blank vi 
1 1/3 Inhibitor ii 
2 2/J Inhibitor iii 
Blank vii 
6 3/4 Inhibitor iv 
Blank viii 
lJ 3/4 Inhibitor v 
Blank ix 
Antiserum Concentration 
1/20 1/40 1/80 
+++ +++ ++ 
+++ + :.t 
-!'-t-t t+ + 
...... -t-t-t 
-++ 
+-ti' i"-!-~ .. 
1/3 
2/3 
J/4 
J/4 
2/3 
J/4 
J/4 
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Table XI 
Agglutination with Treated Inhibitors 
Ethanol o;; 
0 Inhibitor xiii 
4 Inhibitor x 
Blank xiv 
8 Inhibitor xi 
Blank xv 
17 Inhibitor xii 
Blank xvi 
Antiserum Concentration 
1/20 1/40 1/80 
+++ ++ + 
~ 
-t-! -t-!-
+ + 
-t++ ++ 
From t hese t wo experiments, the following conclusions 
may be drawn: 
(a) At 37°c., for 30 minutes, """" 3% ethanol does not 
destroy the antigen, ..._ 6% ethanol destroys all but a small 
amount, ~ 14% ethanol destroys all noticeable activity. 
(b) At 8°c., for 12 hours, 4% ethanol does not destroy 
the antigen, .- 8% ethanol may give slight denaturation, ....... 17% 
ethanol gives considerable denaturation. (In the case of 
the 17% ethanol, at 8°c., the effective titer of the anti-
serum is the same for both the blank and the inhibitor . 
The conclus i on which is drawn for this cas e is bc. sed on the 
observa tion of the difference in t h e s trength of the agSlutina-
tion.) 
Oxidation. Equal volumes of 1/1000 hydrogen peroxide and 
the inhibitor were allowed to stand at room temperature 
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(28°C.) for 5 minutes. Antiserum was added, and the mix-
ture was heated for 30 minutes at 37°c., as usual, before 
the addition of cells. Activity was retained after this 
mild oxidation. The presence of the peroxide did not 
interfere with agglutination, as shown by a suitable control. 
Lyophilization. Lyophilization is a convenient method of 
preserving protein preparations, provided that the process 
does not denature them. 
1. A sample of the KOH-SAS prepara tion was lyophilized. 
Activity was lost. 
2. A sample of a s troma suspension was checked for 
activity, and then lyophilized. The dried material was 
subjected to the KOH-SAS treatment, and again, the product 
was found to be inactive. 
Extraction with Organic Solvents. Though previous work had 
indic a ted that there was little chance of obtaining any 
active Rh substance by solvent extraction, nevertheless the 
following experiments were tried. 
The method mentioned by Block (20} was employed, with 
the following sources of antigen: (a} 5 milliliters of Rh 
positive, type 0 cells; (b) 2 milliliters of a preparation 
from positive cells; (c) 2 milliliters of another prepara-
tion from positive cells; (d) 2 milliliters of a preparation 
from negative cells. 
These materials were extracted twice with 2 volumes of 
ether, followed by two extractions with 2 volumes of ethanol, 
and two more extractions vvi th 4 volumes of ether. Each of 
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the extracts was evaporated and the product was tested. 
None of the materials gave any active extracts. 
In another experiment , a sample of a preparation v,;as 
lyophilized, and t wo saraples of 100 milligran1s each were 
extracted wi th ether in one case, and with a mixture of 
ether and ethanol (9:1 by volume ) in another case. Ex-
tractions were made at -25°c., in accordance with the 
recommendations of MacFarlane (19) . Neither of the eva-
por2ted extracts yielded any activity. 
Fractionation 
Ammonium Sulfate. Aft er an initial KOH treatment, different 
preparations were treated with a i f rerent concentrations of 
ammonium sulfate. A concentration of this salt equal to 
about 1/3 s a turation was the minimum amount which would 
yield a precipitate. Such a precipitate was active. Fur-
ther addition of arrunonium sulfate gave an additional pre-
cipitate, of about the same degree of activity. No marked 
fractionation, therefore, was obtained in this manner. 
Concentrated Salt Solution. An attemp t was made to break 
up the stroma to a greater degree by an intermedia te treat-
ment with 10% NaCl in the preparation or the antigen ic 
material. Ten milliliters of a ~ troma suspension were 
treated with 20 milliliters of a 0.01 N KOH solution for 
4 days in the cold. The re sulting precipitate was centri-
fuged down, and made up to 15 milliliters with water. NaCl 
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was then added to g ive a final concentration of salt of 
10%. After the mixture had stood overnight in the cola, 
it was centrif'uged. The supernatant was brought to half 
saturation with ammonium sulfate and the resulting small 
precipitate ·was centrifuged of f, washed, and re-suspended. 
A slight 2ctivity was shown. The first precipitate from 
the concentrated salt solution had more activity. Apparently 
but little break-up of the stroma had been effected. 
A further at-c.empt was made to fractionate the product 
of the KOH-SAS treatment. Fifty milliliters of a suspension 
of this product were adjusted to a concentration of 1 0% 
NaCl, and the pH adjusted to 7.89 with 0.1 N KOH. The 
mixture was held at 37°c. for JO minutes, when 20 milli-
liters were taken ofr and centrifuged at 17,000 r.p.m. 
for JO minutes. The s up ernatant was dialysed against 
saline. The precipitate was suspended in 20 milliliters of 
phosphate burrer, at pH 7.36. The supernatant had but 
slight, i1' any, activity, whereas the precipitate showed a 
strong inhibitory action. 
A similar test wa s run in which a sample of' the same 
suspension VJas used for the starting material. Sodium 
chloride was added to a final concentrate of 10%, and the 
solution divided into 2 portions. One portion was adjusted 
to pH 6.18, and another to pH 8.0. Both were held at 5°c . 
for 3 days, and then were centrifuged at 17,600 r.p.m . for 
25 minutes. The supernatants were dialysed against saline, 
and then tested for activity. None was found, so apparently 
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the treatment did not further degrade the cell . 
Alcohol Fractionation. Half of the precipitated fraction 
from 50 milliliters of cells was suspended in sufficient 
saline to bring the total volume to 30 milliliters. Twenty 
milliliters of phosphate buffer, pH 7.4, were added, fol-
lowed by 30 milliliters of ethanol. A precipitate which 
could be readily centr ifuged aown was obtained. About 25 
milliliters of this packed precipitate were added to 100 
milliliters of the above buffer. Meanwhile, the s upernatant 
from the alcohol precipitation, after standing 2 hours in 
the cold, yielded another heavy precipitate which was re-
moved and suspended in buffer. The supernatant from this 
precip itation was brought to half saturation wi th ammonium 
sulfate, and a third precipitate was obtained. This was 
taken off, washed, and re-suspended in buffer. All of the 
precipitates, and the first two supernatants, were tested 
for activity. None was f ound. Subsequent work indicated 
that the alcohol had probably denatured the active sites. 
Formamide. The procedure of Morgan and Partridge (28) 
was followed, except that the starting material was a sus-
pension, rather than a dried material, and heating was 
avoided. Ten milliliters of a slurry of the KOH-SAS product 
was treated with 87 milliliters of formamide. This mixture 
stood 3 hours in the cold, and then 200 milliliters of 
ethanol were added. The mixture was allowed to stand 
overnight in the cold. The slight precipitate which 
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formed wa s taken of1' , suspended. in phospha te bui'f'er, pH 7. 3, 
and dialysed against the same bur rer. To the supernatant, 
a nother 100 milliliters ot ethanol were adaed, and the mix-
ture allowed to s t and for 12 hours. The new precipitate 
which formed was dialysed aga inst a saline-buffer mixture. 
Neither of the suspended precipitates gave any inhibition. 
Trichloracetic acid. An extractive procedure as given in 
Kbbat and Mayer (29) was followed in this experiment. 
Tvventy-f'i ve milliliters o1' a suspension of the KOH-SAS 
proauct (about 1.7% by weight) were mixed with 25 milliliters 
of 0.2 N trichloracetic acid. Centrifuging at 14,000 r.p.m. 
for 10 minutes gave a precipitate which, in another experi-
ment, was s hown to be inactive. The supernatant was then 
d~alysed against water to get rid of the acid. Cold ethanol 
was then added to g ive a final concentration of 68% ethanol 
(by weight). Evaporation in a current of air eventually 
yielcied a pre cip it s. te. This was centri1·uged, and to the ~ 
milliliter of packed precipi t a te which resulted were added 
l milliliter of saline and 1 milliliter of phosphate buffer, 
pH 7.4. This suspension gave no activity. 
In another similar experiment, the supernatant which 
resulted after the ad~ition of the trichloracetic acid and 
subsequent centrifugation was dialysed against saline , and 
evaporated to yield an inactive precipitate, and a non-
specifically active supernatant. 
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Trypsin Treatment. The products of the KOH-SAS trea t ment 
were treated ·with trypsin in an attempt to obtain a further 
degradation. 
Experiment 1. Five milliliters of a packed inhibitor solu-
tion were s usp ended in 15 milliliters of phosphate buffer, 
pH 7.3, and 0.5 grams of trypsin* were edd ed. The mixture 
was allowed to stand for 2 days at 5°c., and then the pH 
was adjusted to 8.J with 0.1 N KOH. After this mixture had 
stood another 12 hours at 5°c., 100 milligrams of trypsin 
were added, and the whole was lrnpt at 5°c. for another .3 
days. A centrifuging a t 3,000 r.p.m. for 10 minutes 
brought down a small precipitate which was discarded. The 
supernatant was brought to half saturation with ammonium 
sulfate, allowed to stand for 12 hours at 5°c. and then 
centrifuged at .36,000 G for 15 minutes. The precipitate 
thus obtained was suspended in 10 milliliters of phosphate 
buffer at pH 7 . .37, and re-centrifuged at 40,000 G for 30 
minutes. One milliliter of the s uperna tant obtained from 
this procedure was dialysed against 3 milliliters of the 
phosphate bui'!'er. A sample taken from inside the dialysing 
bag wHich contained the supernatant still showed activity. 
The outer (3 milliliter} portion, which would contain the 
dialysable material, showed no activity. Centrifuging 
another portion of the supernatant a t 900 r.p.s. for 2000 
seconds yielded a supernatant which could be carefully 
*Nutritional Biochemicals Corporation, 1-300. 
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separated from a precipitate, which gave good inhibitory 
action. Addition of ethanol to the supernatant to a final 
concentration of 28%, and heating for 30 minutes at 37°C. 
destroyed the activity. The precipitate, when suspended in 
buffer and used in an inhibition test, caused lysis of the 
added erythrocytes. This may have been due to the action 
of some of the original trypsin which may have been carried 
along in the procedure. A flow sheet of this procedure is 
shown in fi gure I. 
Experiment 2. The specificity of the action in the above 
experiment was questioned, so another experiment was set 
up in wh ich both Rh positive and. Rh negative cells were 
used. Smaller quan t ities of trypsin were used. 
The KOH-SAS trea t ment was done as usual on 20 milli-
liters of cells, and the product was treated with 0.05 
grams of' trypsin for 3 days. 'l1he supernatant from a light 
centrifugation , after a mild alkali treatment as above, 
and another simil2r trypsin treatment, was again lightly 
cent r ifuged. The new supernatant was treated with an equal 
volume of saturat ed an@onium sulfate and re-centrifuged at 
38,000 G. This gave a precipitate which was suspended in 
phospha te buffer, and re-centrifuged a t 40,000 G for 30 
minutes. The supernatant was inactive . The re-susp ended 
precipitate was active in a non-specif ic manner, as indi-
cated by a test with the product from Rh negative cells. 
However, a great er inhibitory action was obtained with the 
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Figure I 
Flow Sheet of Trypsin Treatment 
5 ml. packed inhibitor 
! 15 ml. phosphate bu1'fer pH 7.3 
l 0. 5 grns. trypsin for 2 days 
J 0 .1 N KOH to pH 8. 3 
l 12 hours 
l 100 mgm. trypsin 1'or 3 days 
Centrifuge 3000 r.p.m. tor 10 min. 
(discara.} 
! Equal volume saturated ammonium sulfate 
l 12 hours 
36,000 G for 15 min. 
Supernatant recipitate 
J: 1 ml. 
(discard) 
Superna 
I 
Dialyse against 3 ml. 
hosphate buf1'er pH 7.37 
Dialysable 
Portion 
Activity 
Non-dialysable 
Portion 
No activity 
l lO ml. phosphate , buffer pH 7. 37 
Centrifuge 40,000 G 
f'or 30 minutes 
(discard} 
1 Centrifuge 900 r.p.s. 
for 2000 seconds 
Super~t~ipitate 
Activity Lysis of 
cells J EtOH to 28% 
!Heat ~ hour at 37°c. 
No activit,r 
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product from Rh positive cells, so some specific activity 
i s presumed to have existed. 
Exoeriment J. In another preparation, using only Rh posi-
tive cells , JO milliliters of the packed KOH-SAS product 
were suspended in 60 milliliters of phosphate buff er at pH 
7.36, and 10 milliliters of this material were treated with 
100 milligrams of trypsin after being brought to pH 8.5 
with 0.1 N KOH. 0 After heating for 15 minutes at 37 C., fol-
lowed by 6 hours in the cold, the product was lightly cen-
trifuged, and the supernatant re-centrifuged at lJ,500 
r.p.m.* for 20 minutes. The precipitate from this centri-
fugation was suspended in 10 milliliters of buffer, and 
another 100 milligrams of trypsin were added. After l 
hour in the cold, this was centrifuged at 13,500 r.p.m.*for 
20 minutes. An attempt was made to rid the supernatant 
of the trypsin by two precipitations at 0.4 saturation of 
ammonium sulfate, with subsequent centrifugation and re-
solution of' the precipitate. The trypsin should remain in 
the supernatant fr action. The final step was dialysis to 
get rid of the amn~onium sulfate. This product was active 
in an inhibition test. 
The supernatant from the high speed centrifuging after 
the first trypsin treatment was brought to 0 .4 saturation 
with ammonium sulfate and re-centri~uged. The precipitate 
was vmshed with 0.4 saturated ammonium sulf2te and dialysed 
against saline. After another re-precipitation, solution , 
* 23,000 G 
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and dialysis, the product was tested, and found to be 
active. A flovv sheet of this operation is shovvn in :E'igure 
II. Material derived from a re-precipitation of the trypsin 
stock did not show any inhibition. 
Exceriment 4. As another check on the specificity of the 
action, another experiment using Rh po s itive and .R.,.~ nega-
tive cells was performed. Two trypsin treatments were 
done. Approximately the same ouantities of material were 
used as in Experiment J. Af ter each treatment , light centri-
fuging of the material under investigation yielded a super-
natant which was use d f or the next step. After the last 
trypsin treatment, a precipitat~ was obtained by bringing 
the solution to 1/3 saturation with anmwnium sulfate. This 
was dialysed against phospha te buffer, and was found to be 
active. The results were as s hown below. Proauct II was 
the material before the trypsin treatment. Product III was 
the t obtained after one trypsin treatment. Product IV fol-
lowed the last trypsin treatment and ammonium sulfate pre-
cipitation. In all cas es, parallel runs were done wi th 
similar products derived from negative cells. The resul-cs 
of the titrations with inhi bitors prep ~red from such cells 
were uniformly the same as the one which is shown. It is 
seen that the enzyme treatment slowly destroyed the activity 
of the inhibitor. 
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Figure II 
Flow Sheet of Trypsin Treatment 
10 ml. suspension 
1 vol. slurry in 2 vol. buffer pH 7.3 
l 0 .1 N KOH to pH 8. 5 
1 100 mgm. trypsin 
l 37°c. for 15 min. 5°c. for 6 hours 
~-C.;__entrifuge 5 min., 3,000 r .p.m. 
(di s card) 
J centrifuge lJ,500 r.p.m. for 20 min. 
~-----------~,,,____ Supernatant Precipitate 
Supernatant 
(discard) 
Precipitate 
l Wash with 0.4 SAS 
l Dialyse vs. 0.9% saline 
Active Suspension 
~SAS 
Supernatant Precipitate 
(discard ) 
l dis s olve in water 
l O.ialyse vs. saline 
110 ml. phosphate buffer, pH 7.34 
1 100 mgrn. trypsin 
! 5°c. for 1 hour 
20 min., 
Precipitate 
(discard} 
Supernatant 
(di s ce. rd} · 13 ml. water 
SAS 
Superna ant 
Active Susoension (di s cara ) l3 ml. water 
~ml.SAS 
Superna tant Precipitate 
(discard} 
ldialyse vs. 0.9% NaCl 
Active Suspension 
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Table XII 
Eff'ect of Trypsin Treatment upon Inhibitor Activity 
Antiserum Concentration 
Inhibitor 1/16 1/32 1/64 1/128 1/256 1/512 1/1024 
Product II +-+ + ... ... 
Product III -t-t-t -t 
Product IV i- -t-! -!'-!' -t 
Negative 
Product -t--t~ -t-t~ -t-t -t 
Saline ++ -t -t-t +~ + + 
Immunization. An attempt to develop a rabbit anti-Rh serum 
was mei de, with a sample of the KOH-S.AS preparation injected 
along with a protein carrier, or adjuvant, as the antigen. 
The general procedure as given in Kabat and Meyer (30) 
was followed. One hundred milligrams of dried mycobacterium 
butyricum were suspended in 15 milliliters of' mineral oil. 
Twenty milliliters of a quaphor were warmed to melting and 
mixed with 20 milliliters or a suspension of a preparation 
of the degraded s troma. This prep aration contained 8.7 
milligrams of protein material per milliliter or suspension. 
The bacterial suspension was added, and 10 milliliters of 
mineral oil were added to make the mixture more fluid. 
Merthiola te to g ive a final concentration of 1:5000 was 
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added as a preservative. 
T\vel ve r abbi ts i~i ere injected in traperi tone ally with 
~ milliliter of this suspension. Seven injections were g iven 
over a period of 2 weeks, and then the animals were rested 
for 2 weeks. Another 4 injections were given, and 10 days 
after the last injection the animals were bled. 
A sample of the pooled serums was serially diluted 
and agglutination tests were run on Rh positive and Rh 
ne gative cells. The end points were approximately the same 
with either cell sarn.ple, at a di lution of 1/81 0 1· the 
serum. Two tenths of' a milliliter of' the serwn were then 
diluted with 2 milliliters of saline and absorbed with 0.2 
milliliters of packed Rh negative, type 0 cells, for 90 
minutes a t room tempera ture. An agglutination test on this 
absorbed serum, with Rh positive and R11 negative cells, did 
not show any indication of specific anti-Rh agglutinins. 
A l milliliter sample of" this absorbed serum was then again 
absorbed with 0.2 milliliters of packed Rh negative, type 
0 cells. An agglutination test with both types of cel l s 
showed a very slight indic a tion of the presence of some 
anti-Rh agglutinins, but the effect was too small to be 
significant. A similar test was made with trypsin treated 
cells, and no real difference was seen. These results 
are summarized in the table below. It was concluded 
that no specific antibodies were developed by this 
procedure. 
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Table XIII 
Effect of Absorpti on of Antiserum upon Specifi c 
Rh Agglutination 
Agglutination 
Posit ive cells 
Negative cells 
Pos itive cells 
Negati~e cells 
Antiserwn Concentration (Unabsorbed } 
1/9 1/27 1/81 1/243 1/729 
... 
.. 
Antiserwn concentration (Absorbed once} 
1/10 1/20 1/40 1/30 1/160 
++ 
++ 
Antiserum concentration (absorbed twice) 
1/10 1/20 1/40 1/80 1/160 
Positive cells + 
Negative cells i 
Pos itive cells 
(treated ) 
Nege tive cells 
(treated) +"""" 
.. 
+"""" .. 
+ 
Conclusion. Strama could be degraded to smaller particles 
whi ch g<: ~ve a strong and specific Rh a c ti vi ty. They were 
not readily refractions ted to yield a true solution of a 
hapten. Treatment with trypsin seemed to denature the Rh 
site slowly. l,lhile there was some inhibitory activity in 
the supernatant fra ctions which were obtained after a 
trypsin tre a tment , it is felt that the specificity of this 
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action is still questionable, and should be investigated 
further before any conclusions may be drawn. Denaturation 
by heat occurred readily, especially if the pH of the sus-
pension of the inhibitor material were below 7 or above 9. 
Ethanol rapidly denatured the specific site. Lyophiliza-
tion destroyed its activity, but mild oxidation did not 
affect it. 
Rabbit anti-Rh antibodies were not developed ·when 
this material was injected intraperitoneally along with 
a carrier, mycobacterium butyricum.. 
DISCUSSION 
From the acti on of different reagents upon cells and 
upon stroma, with respect to Rh activity, some conclusions 
may be drawn. 
Th Rh hapten is not like the Forssman hapten, or like 
A and B substance , in solubility or stability characteris-
tics. It is not soluble in methanol , ethanol, acetone, 
dioxan , ether , or ether-alcohol mixtures. A preliminary 
treatment of erythrocytes with either ethanol , methanol, 
acetone or d ioxan does not render the antigen soluble, in 
undenatured form at least, in such lipid solvents as 
methanol, ethanol , ether, chloroform, acetone , dioxan, or 
toluene. The active portion is, therefore, probably not 
entirely lipid or polysaccharide in nature. 
The ready denaturation by alcohol, pH change, or heat 
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all point to a protein-like structure in the active por-
tion of the site. The destruction by trypsin is added 
confirmation of this. On the basis of the apparently s low 
destruction by this enzyme, the absence in the specific 
Rh region of certain trypsin sensitive linkages might be 
postulated. The denaturation due to lyophilization indi-
cates the poss ibility of a lipoprotein structure. 
The failure of several me thods of fractionation of 
stroma particles to yield an active extract seems to indi-
cate that the Rh site is a reasonably integral par t of the 
surface of the ce l l wall. It is probably no t a s epa r a te, 
isolable region of a particular protein or lipoprotein con-
f'igura tion, which differs in mol ecular structure from the 
rest or the cell wal l . Rather, it probably represents a 
relatively minor a.i f'f erence in the coni'iguration of the 
molecular constituents of the wall. The properties of this 
region, with r espect to solubility in different media, are 
probably but litcle a.ii fe rent from the properties of any 
other region of the ~all, and h ence its isolation will be 
very hard. 
If the Rh re gion possesses no outstanding structural 
char·acteristics, compared to the rest of the cell, the 
failure of' Rh positive cells, when inj ected into animals, 
to yi eld a h i gh concentrat i on of anti-Rh antibodies may be 
explained. Antibodies are built up against all the 
different portions of the cell wall which constitute the 
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antigen, and there is no preferential manufacture of antibody 
against the Rh site. Those antibodies which are directed 
against this site are in such low concentration that they 
escape detection. In the work with alcoholic extracts, 
the antigenic site was probably denatured, so o.ny specific 
antibody i' orm&tion would be impossible. 
-6J-
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THE FRACTIONATION OF Al'IJ ANTI-Rh ANTISERUM 
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I NTRODUCTION 
Blood serum may be divided, by salt precipitation 
methods, into two fractions, the albumin fraction and the 
globulin fraction. Many experiments have shown that only 
the latter fr action contains those proteins wh ich are 
forme d as a result of an antigenic stimulus, and are called 
antibodies. Electrophoretic analyses have shown that the 
globulin protein may be subdivided into three major groups, 
the a. - , (3 - , and "'1 - globulins, which differ among t hem-
selves in their molecular weight and also, at a g iven pH, 
in t heir electrical charge. Antibodies have nearly always 
been f ound in the ~ - globulins, although a recent work by 
Enders (l} showed tha t the human antibody to typhoid 0 
antigen , ana all of the isoagglutinins, were contained in 
a fraction of t he serum which contained 70% 1 - globulin, 
and 25% ~ - globulin. He concluded that t h is antibody was 
probably in a fraction which differed from the usual ~ -
globulin, and l a t e r Deutsch (2) sh owed tha t the antibody 
was in a subtraction o:t· the 1 - globulin which he termed 
~. - globulin. This wa s the first demonstration of differ-
ences, other t han serological, in human antibodies. 
Dil'ferent types of Rh antibodies, which have different 
serological a ctivities, have been recogn ized. The first 
type is the one which causes agglutination of Rh positive 
cells, when the cells are s uspended in a saline medium. 
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A second type, cal led the blocking antibody, inhibits the 
agglutina tion of' Rh positive cells by an agglutinating 
cntis erwn. A t hird type, variously called a develop ing 
antibody, a t h ird order an tibody, or a cryptagglut i noid , 
is recognized by the f ollowing reactions. 
This antibody will form a specific compl ex with an 
Rh positive er yt hrocyte, but the 1'ormation of' t h is complex 
does not lead to either agglutina tion or blocking. However , 
if t here i s added a t hira component which will combine in 
a specif ic manner with the complexed. cells (but not with 
the non-complexed cells ) , agglutination \Ni l l t c.: k e place. 
Such e. third component is found in the antibodi e s which 
are f ormed in a r ab bit af ter the animal ha s been inj ecte d. 
with human globulin. Thes e antibodies combine specif ically 
with human globulins, and therefore their union with the 
developing antibody gl obulin on the above complex ca n ul-
tima t e ly result in an agglutination of the cells. It 
should be noted t hat both oi· t he f ir s t mentioned types of 
antibody will al s o give a developing test . However, the 
antibody which will subs equently be referred to as the 
develop ing antibody i s tha t one which causes neither agglu-
tina tion nor block i ng, but g ives only this test. 
The postula ted. mo des of action of these di1'rerent 
antibodi es a re shown in F i gures I - III. In Figure I , the 
erythrocyte (E J is dep icted, with some antigenic sites (A) 
on its s urf a ce. These sites are combined speci:t' ically 
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with corresp onding antibody sites on the molecule of the 
agglutinating antibody (B ). I f both the erythrocyte and 
the antibody contain more than one combining site, and 
these sites are suita bly arranged so that steric factors 
are not a cons i a eration, it can be seen tha t a large number 
of erythrocytes may be linked together wi th the possible 
· ultima te formation of a visible clump. 
HowBver, ir the antibody molecule has only one com-
bining site on it, no coupling between the complexed cells 
may be formed, and so no agglutination can take place. If, 
in adaition, the combining sites of the cell are al~ covered, 
the agglutinating antiserum will. be ineffective when it i s 
added to the system.. This is shown in Figure II, in which 
{ C} indicates the blocking an tibody. VJhile this pie ture 
of the a ction of a univalent an tibody may not be strictly 
correct, owing to our lack of aetailed knowledge of anti-
gen-ant ibody reactions, it nevertheless may serve as a 
useful approximation to what is tak ing place. It assumes 
that the dissociat ion constant of the cell-agglutina ting 
antibody complex is at most not much greater tho.n the dis-
socia tion constant of the cell-blocking antibody complex, 
and that the t wo types of antibodies are present in ap-
proximately e qual concentrations. 
Figure III shows the se ouence of re a ctions in the test 
for the a eveloping antibody. The erythrocyte (E) combines 
with the specific &ntibody (D). In this case, the Rh 
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antigenic site is marked (A'). Sinc e the developing 
antibody does not necessarily show a blocking activity, 
the site of its <: ct ion on the erythrocyte r.J.ay d i ff er from 
the s ite of action of the other two types of antibodies. 
Nevertheless, the common Rh specificity seems to point to 
some sort of relationship between the reg ions of' the ery-
throcyte which respond to the first two types of anti-
bodies, and thos e reg ions which respond to the third type 
of antibody. 
The antibody (D) now, by virtue of its globulin nature , 
has an antigenic site on it which specif ically reacts with 
the r abo it anti-globulin serum. The an tibodies (R) in this 
antiserum a re pr esumably multivalent; thus the complex of 
the cell plus develop ing antibody may be built up to pro-
portions wh ich a re visible to the eye. 
A separation of agglutina ting and blocking antibodies 
on the basis of their solubilities was made by Witebsky (3) 
wh o dialysed an an ti-Rh serum against water, to obtain a 
wa ter-insoluble globulin, and a wa t er-soluble globulin. 
The former traction was soluble in saline; this solution 
gave a typ ic al agglutination test with Rh positive erythro-
cytes. The water soluble traction showed the presence of 
block ing and of developing antibodies. 
An a ttemp t to obtain a more precise .t're ctiona tion of 
these c:ntibodies through t he use of ion-exchange resins 
was msde by Hill and Haberman (4). Blocking antibodies 
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Figure I 
Mechanism of Agglutination Reaction 
Figure II 
Mechanism of Blocking Reaction 
Figure III 
Mechanism of Developing Reaction 
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and some developing antibodies were found in the water 
soluble globulin frc:ction. The water insoluble portion, 
which contained the a. -, (3 -, and --6 -globulins, was 
fractionated by aifferential solubility in NaCl solutions 
of di1'ferent concentrations. Agglutinating antibodies 
v·:ere f'ound in the ; - globulin fraction, while developing 
antibodies were found mainly in the ~ - globulin fraction. 
It should be noted that this final fractionation and 
characterization is quite rough - e.g. the fraction labelled 
as a ~ -globulin probably conta ins much of the other 
globulins. 
A s ep 2r a tion by electrophoresis-convection seemed to 
offer an excellent means f or carrying out a fr actionation 
s tudy. The trea t ment of the protein is very mild, so de-
naturc: tion should be at a minirnwn, in contras t to the ion-
exchange process, where the effect of the treatment up on 
the protein may be considerable. The separation of the 
serum into its con;_p onents is much more satisfactory, in 
that fractions of a higher purity and of known composition 
may be obtained. 
A fractionation of' an <.. ntiserum by this method had 
been carried out in these lEbora tories by Cann et al (5 } 
and it had been concluded that the blocking antibody 
appeared to be associated with a ~ -globulin fra ction of 
l ow mobility. About 75% of the a eveloping ant i body ap-
peared to be in the ~ -globulin, but the remaining 25% 
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appeared to be associated with the a. - and/or the (3 -
globulin. A second anti-Rh serum was investigated to 
study the pattern of the antibody distribution, and the 
results of this work are presented below. 
I 
EXPERIMfu~T.AL 
Materials and Methods 
Fractionated An ti serum. 'rhis was an anti-Rh serum sent 
here by Dr. R. Day, of New York. The donor was an Rh 
negative woman, Vv'h o delivered an Eh positive child which 
subsequently showed symptoms of erythroblastosis fetalis. 
The donor had had two blood transfusions as a child, and 
"' these may have sensitized her - i.e. caused an antibody 
production aga inst the (probably) Rh positive cells whi ch 
would be used in the transfusion. At the time of the delivery, 
anti-Rh antibodies could be dete cted in the maternal 
circulation, and the antiserum sample was taken a few days 
after the birth of the child. This was antiserum I. Four 
months later, another sample of blood was taken from the 
same donor and the serum therefrom was shipped here. This 
sample was called antiserum II. Both of these samples 
were fr~ctionated according to the procedure to be 
described. 
Agglutinating .bntiserum. This was an antiserum sample 
obtained from Hyland Laboratories. It caused agglutination 
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of Rh positive cells at all dilutions up to (i.e. more 
concentrated than) 1:512. 
Rabbit Anti-Globulin Serum. For the tests on fractions 
from antiserum I, samples of sera from three raboits which 
ho.d been immunized with human globulin were pooled and. 
used as a stock. For the tests of fractions from anti-
serum II, the stock was a sample of frozen antiserum from 
a s imilarly i rmnunized r c: b oit. On each day that tests were 
run, a portion of the frozen antiserum was thawed out and 
treated as below. 
The antiglobulin serum iNas diluted with an e qual 
volume of saline, and then absorbed once, at room tem-
perature, for 1 hour, with 2 volumes of packed., well washed 
erythrocytes. (Adequate washing on the absorbing cells 
was very necessary, as otherwise traces of normal serum 
globulins which adhered to the ce l ls parti ally neutralized 
the rabbit entiserum.) The erythrocytes were then centri-
fuged off, and the absorbed antiserum was again diluted 
with saline until the final concentration was 1/6 that of 
the original antiserum. 
Human Erythrocytes. For tests on antiserum I, a pool of 
Rh positive, type 0 cells was used. It was endeavored to 
obtain cells not more than 2 or J days old, at the very 
most. On antiserum II, the Rh positive, type 0 cells were 
drawn from one donor f'or all the tests. They were never 
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more than 1 day old at the time that the tests were run. 
The cells were washed and suspended in isotonic saline, 
• 1 ,, to a final concentration of 2~ - 5~ by volume. 
Agglutination Test. Two one-hundredths of a milliliter 
of the erythrocyte suspension were incubated in 13 x 100 
millimeter test tubes with 0.02 milliliters of dilutions 
of the fraction to be tested, for 10 minutes at 37°0., and 
for 20 minutes at room temperature (27°c.). After light 
centrifuging, the tubes were examined to see if agglutina-
tion had taken place. A second centrifuging and re-examina-
tion were done as a check . Doubtful cases were examined 
microscopically. In all cases to be reported , no agglutina-
ting antibodies were found , so further mention of them will 
be omitted. 
Blocking Test. To the cells and test antiserum used in the 
test above, 0.02 milliliters of a 1/128 dilution ( in saline ) 
of the agglutinating antiserum were added. The tubes were 
re-incubated for 30 minutes at 370c., and then centrifuged 
and examined, as above , for agglutination. The reciprocal 
of the value of the highest dilution which still completely 
inhibited agglutination was called the titer of the 
blocking antiserum. 
The amount of agglutinating antibody which was added 
was four times the minimum amount necessary to just g ive 
agglutination. In spite of this excess, though, t he 
presence of small quantities of blocking antibody could 
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be shown. The minimum amount of the latter which was re-
ouired to give a blocking titer of 1 to the fraction under 
test was that amount which would completely inhibit agglut-
ination in the first tube of a series of serial dilutions. 
If there were less of the blocking antibody present, there 
would be agglutination of the erythrocytes, but this agglut-
ination would be weaker than in a control experiment, in 
which no blocking antibody had been added. Observations on 
the strength of agglutination were based on the ease with 
which a clump of agglutinated cells broke up, with gentle 
shaking. 
Developing Test. Two one-hundredths of a milliliter of the 
erythrocyte suspension were incubated for 30 minutes at 37°c. 
with 0.02 milliliters of serial dilutions of the fraction 
to be tested. 'The cell suspension was then washed 3 times 
with 0.5 milliliters of 0.9~ saline. After the last washing, 
as much as possible of the supernatant was removed from the 
centrifuged cells, and then 0.02 milliliters of saline were 
added, with 0.02 milliliters of the prepared anti-globulin 
serum. The tubes were shaken, incubated at 37°c. for 30 
minutes, and examined for agglutination after light cent-
rifuging. The reciprocal of the value of the lowest con-
centration of the test fraction which gave agglutination 
was taken as the developing titer of the fraction. 
Fractionation Procedure. The antiserum was fractionated in 
the electrophoresis-convection apparatus which has been 
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described by Kirkwood et al (6}. Figures IV and V show the 
fractionation scheme, as well as the buffers used and the pH 
values at which the fractionations were done. For all buffers, 
r/2 = 0 .1. The last bottom fraction was salt fractionated 
into an albumin fraction and a globulin fraction. 
Results 
The re sults of the electrophoretic analyses of the 
various fractions which were obtained are shovm in 'I'able I 
and Table II. Figure VI shows representative electro-
phoretic patterns from the fractionation of antiserum I. 
Table III and Table IV show the results of the tests 
of the fractions for the different types of antibodies, as 
well as the volumes of the different fractions and their 
protein concentrations. Figures VII and VIII show the titer 
and concentration values in graphical form. 
Some of the top fractions were concentrated to see 
(a} if antibody titers could be raised, (b} if the degree 
of improvement was proportional to the increase in the 
concentration, and (c) if some titer could be obtained in 
those cases where no titer had previously been found. Three 
concentration methods were used: i. perevaporation with the 
aid of an infra-red lamp; ii. perevaporation in the cold 
room; iii. lyophilization. 
Tables V and VI show the results of these concentration 
procedures on those samples which had been treated. 
Top 144 
Top 145 
Top 146 
Top 150 
Top 151 
Top 152 
Top 153 
Top 154 
-75-
]figure IV 
Serum I 
Phospha te Burrer pH 6.87 
Bottom 141 
C Phospha t e Bui'f er pH 5. 50 
I 
Bottom 144 
C Phosphate Buffer pH 5.50 
I 
Bottom 145 
C Acetate Buf!'eI' pH 5.30 
I Bottom 146 
Half s8 turation with 
c==ammonium sulfate 
I Supernatant Bl46 A Precipitate Bl46 G 
I 
Figure V 
Serum II 
Phosphate Buf'f er pH 6.98 
Bottom 149 
r== Phospha te Bu1·r er pH 6. 48 
I Bottom 150 
C Phospha te Buff er pH 5. 97 
I 
Bottom 151 
c=Phosphate Buffer pH 5.97 
I 
Bottom 152 
c==Phosphate Buffer pH 5.48 
I 
Bottom 153 
r ceta te Buffer pH 5.31 
I Bottom 154 
Ammonium sulfate to half 
c satura tion 
Supern&tant Bl54 A I Precipit a te B 154 G 
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Table I 
Analysis of Antiserum I Fractions 
Components "i {3 a. a :z.. Albumin 
)1 'fo µ % J.1 ~{, µ % J.l % 
Fraction 
Anti-
serum I 1.47 11 3.12 16 5.14 8 4.04 20 6.30 45 
Tl41 1.36 98 
Tl44 1.54 53 3.27 43 4.81 4 
Tl45 1.64 51 3.27 47 4.45 2 
Tl46 19 3.46 50 4.53 24 6.68 7 
Bl46G 2 5.77 47 4.53 48 3 
Bl46A 3.28 2 5.30 12 4.29 3 6.48 83 
Table II 
Analysis of Antiserum II Fractions 
Components , (3 a., a. z. Albumin 
µ ~o J.1. % µ % µ % µ % 
Fraction 
Tl49 1.18 97 3 
Tl50 1.37 93 3.40 7 
Tl51 1.65 76 3.29 24 
Tl52 1.78 77 3.35 ~3 
Tl53 1.61 42 3.35 58 
Tl54 1.52 12 3.26 37 4.95 37 6.60 13 
Bl54G 2 4.86 57 4.00 32 6.33 8 
Bl54A 3.22 3 5.21 4 4.12 2 6.38 88 
- - - - - - - - - - - - - -
µ is in units of io-5cm. 2volt-1sec.-1 
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Figure VI 
Representative Electrophoretic Patterns from Fractionation 
01· Antiserum 
AJ.l patterns traced 1'rom rising boundaries 
Arrow shows direction or migration 
Scale marked in centimeters 
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Table III 
Analysis of' Antiserwn I Fractions 
Fraction Blocking Developing Concentration Volume 
'fi ter Titer g/100 ml. 
Original 
serum 8 64 7.0 39 
Tl41 l 8 0.25 61 
Tl44 1 16 0.33 45 
Tl45 0 8 0.17 5b 
Tl46 0 8 0.23 50 
Bl41 1 64 J.60 70 
Bl44 71 
Bl45 2 8 2.79 70 
Bl46G 1 8 0.92 50 
Bl46A 0 0 0.34 205 
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Table TV 
Analysis of' Antiserum II Fractions 
Fraction Blocking Developing Concentration Volume 
'ri ter Titer g/100 ml. ml. 
Original 
serum 8 32 7.0 70 
Tl49 1 8 0.37 62 
Tl50 1 2 0.27 56 
Tl 51 0 2 0.22 50 
Tl52 0 1 0.13 45 
Tl53 0 1 0.19 45 
Tl54 0 2 0.40 40 
Bl49 2 32 
Bl50 2 16 
Bl51 2 16 
Bl52 1 8 
Bl53 0 8 
Bl54G 2 8 2.40 34 
Bl54A 0 0 0.50 295 
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Figure VII 
Results of' Fractionation of' Antiserum I 
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Figure VIII 
Results of' Fractionation of Antiserum II 
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Analyses of Antiserum ll 
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Table V 
Serological Activity of Concentrated Fractions of 
Antiserum I 
Fraction Concentration 
Method Factor Final 
(gms./ 
100 ml.) 
Blocking 
Titer 
Developing 
Titer 
Tl41 i, iii 9 2.J * ** 
Tl45 i, iii 12 2.0 4 ** 
Tl46 i, iii 7 1.7 4 ** 
* Antibody may be denatured, either aue to concen-
tration process or to aging (fraction was 2 - 3 
weeks old.) 
**No test made 
Table VI 
Serological Activity of Concentrated Fra ctions of 
Antiserum II 
Fraction Concentration Blocking Developing 
Method Factor :!!' inal 'ri ter Titer 
(gms./ 
100 ml.) 
Tl49 i 3 1.0 8 8 
iii 4 1.3 4 4 
Tl50 i 3 0.9 2 4 
iii 4 1.2 4 4 
Tl51 i 3 0.7 1 2 
iii 4 0.9 1 0 
Tl52 i 4 0.7 1 1 
Tl53 i 4 0.8 1 1 
ii 3 0.6 0 4 
Tl54 ii 3 0. 9 2 2 
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DISCUSSION 
From the results on antiserum I, it is seen that the 
blocking titer was rapidly lost as the fr &ct ionation pro-
gressed. The conclusion is that the blocking antibody 
seemed to be associated with a slowly moving portion of 
the ~ -globulin. The most interesting feature of this 
study is that there was still & strong developing antibody 
titer in the Bl46G fraction, which was 95% o. - globulin. 
This is added confirmation of the results previously ob-
tained by Cann et al, but in the present case the final 
product was a much more electrophoretically pure a. -globu-
lin - i.e. there was less albumin and ~ -globulin in it. 
The variations in antibody titer may be satisfactorily 
explained (within the limits of experimental error) .on the 
assumption that a blocking antibody was present in the 
slowly moving part of the ~ - globulin, while developing 
antibodies Viere present in the a. -globulin as well as in 
the -6 - globulin. Th e existence of c;,.ntibodies in the ~ -
globulin fr action cannot be afiirmed or denied, but it is 
not necessary to assume any antibody in this fr e. ction in 
orde r to explain qualitatively the results. 
Antiserum II vvas divided into more fr actions, but the 
trend of the results was the same, with the rapid disap-
pearance of the blocking titer after the removal of the 
first t wo top fractions, and the consistent presence of 
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the develop ing antibody in all the fractions, including 
Bl54G, which \111 as 89% a. -globulin . 
It ·will be no ticed that the antis erum II had a smaller 
concentration of developing antibody - for a given concen-
tration, the developing titers in the second sarnple vv~re 
uniformly lower than in the first sam_ple. This was probably 
the result of the usual decrease in antibody titer in a 
given donor with time, when no further antigenic stimulus 
is g iven. 
Another difference between the two antibodies is f ound 
in the results of t he concentration studies. In generel, 
there had been an increase which was roughly proportional 
to the concentration factor in the blocking titer of a 
fraction after it had been concentrated, vvhereas the 
developing titer had not increased. There was probably 
some denaturat ion of the developing antibodies. 
The results from fraction Tl53 show some indication 
that ir the perevapora tion is done in the cold, the develop-
ing titer is maintained. A similar indic a tion was found 
in an experiment on another fraction: 
One sampl e of Bl54G was perevaporated with the aid of 
an infra-red lamp; another was perevaporated in the cold. 
Both samples were thus reduced to approximately 1/8 of 
their original volume; they were then made up to the 
or iginal volume with s al ine. (There vms some intermediate 
adjustment of salt concentration to keep the ma t er ial in 
solution, but both samples were treated in the s ame manner.) 
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The sample which was perevaporated vi i th the l amp had 
dropped one tube in developing titer; the one which had 
been concentrated in the cold maintained the original titer. 
The block ing titers were unafrected in both cases. This 
one experiment, unfortunately, is not too s i gnificant because 
of the l a r ge experimental error. 
A useful procedure, and a check on the experiment, is 
to see whether the ~otal amount of antibody, a s judged by 
the tit ers, was maintained. 
Let the number of antibody molecules in each traction 
be n , , n 2 , n$ •.. n i . Let ~he antibody concentration in each 
fraction be c 1 , c z , c;s ... c ( . Let the volume 01' each fraction 
be v, , v z , v3 ••• v< • Let r.he titer of each 1'rac ti on be t , , 
t 2 , t .3 •.. t " . Assume that in the original serum these func-
tions were n 0 , c 0 , v0 , t 0 • If the titer is assumed to be 
a function of the concentration of the antibody, then: 
therefore 
therefore 
If this is applied to antiserum I, the fo l lowing 
results are ob tained: 
Blocking titer t 0 V 0 = 312 
L: ti v, = 156 
Developing titer 
t 0 Vo = 2496 
E t . v, = 2456 
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The agreement of the blocking tit ers is sat isfact ory, 
if allowance is made for the inherent error in t he exp eri-
ment ( a factor of 2} as well as for denaturat i on and un-
avoi dable loss in each operation. If an es timated 5% was 
lost during each of the five s eparations, the re duced 
t 0 v 0 is 312 x (0. 95)5 = 243 - a better agre ement. 
Th e apparently close agre ement of the fi gures f or de-
veloping titers i s not indicative of an excellent check. 
The va lue of t 0 v 0 shoul6 be reduce d by a t leas t the fac tor 
shown above, to allow for los s and possibly a greater ae-
naturation. The reauce d value is 1930. Still, the sgre e-
ment is s a ti sf ectory. 
Th e procedure, appli ed to anti serum II, sho~s a satis -
fa ctory conservation of antibody. 
By using titers obta i ne d from the concentrated samples 
of the differ ent f r a cti ons , t he results of t he blocking 
t es ts are: 
t 0 V0 = 560 
E t i vl = 330 
The re duced t 0 v 0 = 390. This value is calcul a ted on 
the basis of seven operations. 
L: t . ~ for the blocking titers of the unconcentrated 
fractions is 186. Th is is a low value, as s ome of the 
fractions, with a blocking tit er of zero according to the 
exp er i mental procedure, nevertheless contained some antibody. 
Th is was s hown by the observation that t he degree of 
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agglutination, in tubes with the most concentrated samples 
of such fra ctions, while never zero, was less than the ag-
glutination in tubes where the semple under test was more 
dilute. Making a rough correction for this untabulated 
antibody will raise the value given above somevvhat - pro-
bably to 200 or 250. However, this low value is within the 
range of experimental error, when compared to a corrected 
t 0 v0 of 390, so most oi the antibody has been preserved. 
For the developing titers, the corrected t 0 v0 is 1550. 
L:t , ~ 1100. If the I::: t .: v, is calculeted for the concen-
trat ed top fr actions, and. compared to that for the uncon-
cent r ated fractions, a great decrease is noted. 
o:= t (vl } = 31.3 (concentrated} 
(unconcentrated) 
Th is may be accountea for on the basis of dena turation. 
DLferences in amino acid composition of a. - and 1 -
globulins have been reported (7). The di f ferent fra ctions 
obtained by this method of preparation should be analysed 
to aetermine their comp osition. If a ait ference is still 
found, it might mean that dif ferent amino acid arrangements 
might told similarly to yield similar combining site conf i gu-
rations against a particular antigen. These different 
arrangements mi ght be a result or specific antibody produc-
tion by different cells of the reticulo-endothelial system. 
Any dif ference in the structure of such a site mi ght 
be reflected in the susceptibility of the site to denatura-
tion effects. 
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PART III 
A COMPARISON OF THE VASOCONSTRICTOR AC'rIONS OF ADRENALINE 
.AND NOR-ADRENALINE 
-89-
I NTRODUC ':rION 
The classical action of adrenaline (epinephrine) in 
the animal is to cause a considerable rise in the blood 
pressure. This effect ha s been considered to be the re-
sult of a t wo-fold a c ~ion of the drug, viz: 
1. Peripheral constriction of the arterioles, 
2. Direct stimulation of the heart muscle. 
According to Go odman and Gilman (1) t he first effect 
controls, in large mea sure, the level of the diastolic 
pressure. Adrenaline administration constricts the blood 
vessels of the splanchnic bed, as well as those of the 
pulmonary circulation. Euler ( 2) rep orts that the blood 
vessels or the perfused human placenta are constricted, 
under the influence of the drug . On the othe r hand, those 
vessels supvlying the skeletal muscles are dilated (1)(3). 
However , when e.drenaline is aei.niinistered in small 
amounts, there is a fall in blood pressure, presumably 
due to vasoailation (1}(4). This effect is seen when 
subcutaneous injections a re given and the local concentra-
tion of adrenaline at the site of injection constricts the 
nearby blood vessels. The r a te of blood .flow through these 
vessels is c onse quently reduced, and hence the rate of 
introauction of aarenaline into the general circulation 
is also re duce d . The concentration l e vels obtained are 
then much smaller than those which are attained as a result 
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of intravenous injection into a larger vessel. 
Nor-adrenaline (nor-epinephrine, arterenol) on the 
other hand, causes vasoconstriction in nearly all cases (1). 
A vasodilating effect upon the coronary vessels of cats 
and dogs, after administration of this drug, has been re-
ported by Burn and Hutcheon. The same paper also indicates 
that small doses of nor-adrenaline will dilate the intes-
tinal blood vessels of these animals (3). 
Ho 1-1 H H HO c- C-N, 
o H CH 
I-{ J 
HOO ,H 
HO c- C-N,H 
Adrenaline Nor-adrenaline 
Goldenberg et al have made a series of stuaies on the 
relative effects of adrenaline and nor-adrenaline upon 
humans (5)(6). They calculated that t here was a drop in 
the peripheral resiste.nce as a result of administration 
of' t he rapeutic doses of adrern:;.line, and so concluded that 
it acted as an over-all vesodilator. From similar studies 
on nor-adrenaline, they conc l uded that it was present as 
an over-all vas oconstrictor. 
In the present work, the action of adrenaline was r e-
investigated and coo~ared to the action of nor-adrenaline. 
In the work cited above, the dosages were of the order of 
0 .1 microgram of' drug per kilogram of body ·weight per 
minute. These values were just s uff'icient to produce and 
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maintain a desired blood pressure level in the patient. 
The dos ages which were used in the present investigation 
ranged from 3 to 60 micrograms per kilogram injected. over 
a period of about JO seconds. A more direct method of 
measurement was used, and the reflex activities which also 
influence the blood. pressure vrnre eliminated.. 
Goldenberg obta.ined peripheral resistance values from 
calculations based on measurements of arterial pressure 
and cardiac output, according to the formula: 
Total peripheral resistance Arterial pressure 
Cardiac output 
However, according to the calculations of van 
Harreveld, Feigen and Lerman (7) the peripheral resistance 
is not the main governing factor of arterial pressure. 
The lati::.er is mainly dependent on a parameter which is not 
considered in the above formula. These workers derive 
a formula: 
P _ V(R + r) 
C1 R + ( C1 + q) r 
V = Volume of circulating blood 
A = Arterial pressure 
r = A parameter which lumps together some of the conditions 
of operation of the heart, and which effectively repre-
sents the resistance of this pump. 
C, , C 2. are parameters vvhich correspond to a capacity fac-
tor, as represented by the elastic properties of the 
arterial and venous systems. 
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r is rela tively smal l, and if V is as sumed to be con-
st ant, it is se en that the arterial pressure is dependent 
upon c, and is but little affected by R. 
In the 1·01lowing experiments it was assumed that, under 
a constant head, the rate of flow of a liquid through a 
tube was an inverse function of the resistance to that flow. 
This has been corroborated for li quids which have no formed 
elements in them, over moderate pres sure ranges (8). The 
perfusion rate of a solution through the circulatory system 
of a rat was studied, and changes in this rate, upon the 
introduction of a d.rug , were assumed to be a reflection 
of the degree of vasoconstriction, and hence of the resis-
tance to flow, of the blood ves s els. 
EXPERilvIENTAL 
A rat was injected with a solution of fastusol , in 
order to prevent clotting in the subse quent opera tive 
process. After about 10 minutes to allow for the absorp-
tion and circulation of the fastusol, the rat was anaesthe-
tized with ether. Too much anaesthesia was avoided, as 
this apparently made the subsequent response less acute. 
After anaesthesia, the rib cage was cut open to expose the 
heart . The right atrium and the left ventricle were 
cannula ted, and the blood was flushed out of the circulatory 
system by perfusion with oxygenated Ringer's solution. 
This solution was introduced into the ventricle, and t aken 
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out via the cannula in the atrium. The animal was removed 
to a warm room to keep the temperatl.lre at J7°C., and. the 
left ventricle connected to a constant-head input, ~hile the 
cannula from the right atrium was connected to a drop 
counter. In this way, all of the circulation, except the 
coronary and the pulmonary systems, was in the perfusion 
circuit. 
After a steady rate of perfus i on was obtained, the drug 
was introduced, and if there was any eff ect, a second ad-
ministra t ion was not ma de until the perfusion rate had aga in 
reached a steady value. Different concentrations of the 
drugs were used, but in every case the lowest concentra-
tions were us ed f or the initial injection. 
Originally , the drugs were introduced by injection 
with a syringe and needle directly into the rubber tubing 
which connected the reservoir of Ringer's solution with 
the animal. However, any handling of the tubing intro-
duced v ariations in the output r a te, so the apparatus 
shown in Figure I vvas used. 
L consisted of a piec e of 4 millimeter (outside dia-
meter} glass tubing, about 12 inches long , and which was 
jacketed by a 6 inch p iece of 25 millime t er (outside dia-
meter) glass tubing. The latter had an outlet at E, at 
one end, and was sealea to the inner tube at this end. 
Oxygenated Ringer's solution was introduced from R. Clamp 
B was initially closed , after the system had been filled 
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with perfusing solution. Clar!).p A wa s opened enough to 
allow a good flow of liquid. B was then carefully opened 
to allow the Ringer's solution to flow down through the 
animal, under the h ead of pressure Vv'h ich was governed by 
the height at which L was clamped. This height was ad-
justed to e.llow, initially, l to J drops per second. of 
li quid to flow through the animal. Some edema ueveloped 
as a result of this pressur·e, but it did not become severe 
until about an hour after the start of the experiment. 
It did not interfere with the results for any one drug 
injection, although it migh t have been the caus e of the 
general slowing of the drop rate as the experiment pro-
ceeded, t hrough the constriction of the vessels by external 
pressure. With a l ittle practice the pinch clan~ s could be 
adjusted so that there was a s teady flow of Ringer's sol u-
tion into the animal, without the introducti on of air bub oles 
at D. Overflow at D, from t he ne cessary slight excess at 
C, was drained off at E. To introduce the drug solution, 
a bent needle was ins erted at D, and the s olution was 
force d in from a syringe. If the needle tip was held about 
an inch below D, and the drug solution was colored with 
fastusol, the injection could be performed without loss of 
li quid into the overflow. 
The dropwise output from the right atrium was a l lowed. 
to fa l l across t wo wire electrodes which were connected in 
series vvi th a transformer supply and an electromagnet. 
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Figure I 
Apparatus designed to allow the introduction 
of a drug solution into a perfusing fluid, 
without causing any change in the pressure 
under which the latter is f'ed into a system. 
R 
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The armature of the electromagnet marked a kymograph. A 
clockwork timer gave one-second impulses for calibration 
purposes. 
RESULTS 
The number of drops per 10 seconds is plotted , and 
shown in the following graphs. Before and after any in-
jection , points are plotted for every 10 second interval. 
When the rate is more steady, points are plotted at half 
minute or minute intervals. 
It is seen that Qualitatively there is no difference 
in the effect which the two drugs produce upon the circula-
tion, as far as the resistance to flow is concerned. All 
reflex mechanisms are cut out , and the effect is apparently 
a net constriction of the blood vessels . It should be 
pointed out that in an experiment of this type, vasodilation 
will not show up. Even when no drug is present, the 
vessels are relaxed , and probably distended to their full 
extent under the hydrostatic pressure of the perfusing 
fluid . Hence the only effect which may be observed will 
be due to vasoconstriction. 
Metabolic Rate. Goldenberg reported that both adrenaline 
and nor-adrenaline increased the oxygen consumption of 
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huraans. On the other hand, Reale et all ( 9} reported that 
injection of 1-nor-adrenaline into humans at the rate of 
7 - 15 micrograms per minute had no ef1'ect upon the oxygen 
consumption. Lundholm (10) he s indicated that adrenaline 
increases the oxygen consumption of unanaesthetized guinea 
pigs, but that anaesthetic drugs markedly inhibited this 
action. 
The e1"fects of these two drugs upon lightly anaesthe-
tized r abbits were comparea.. A rabbit was lightly 
anaesthetized and a trachea cannula inserted and connected 
with a metabolism apparatus. The administration 01· neither 
of these drugs had. any ef'i'ect u_pon the oxygen consumption. 
It is, however, dirficult to draw conclusions from a com-
parison of the effect of the drug upon humans who are not 
under basal coneii tions ana. the e1'1'ect upon a lightly 
anaesthetized rabbit. 
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Figure II 
Effect or administration of adrenaline and 
nor-adrenaline (arterenol) upon perfusion 
rate 
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Figure III 
Effect 01· administration 01' ae1.renaline and 
nor-adrenaline (arterenol ) upon perfusion 
rate 
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Figure IV 
Effect of administration of adrenaline and. 
nor-adrenaline (arterenol) upon perfusion 
rate 
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PROPOSI'rIOI\fS 
1 . (a} The Coombs' developing test enables blocking anti-
bodies, which are possibly monovalent, to be detected on 
the erythrocyte. A modified developing test, using a 
labelled antigen, may enable reagins to be detected in a 
precipitin test. 
(b} The apparent failure of some animals to develop a 
high antibody titer in the course of an immunization may 
be partly due to the presence of a non-precipitating , and 
possibly monovalent antibody. A modified developing test 
will show the presence of such antibodies. 
2. 'rhe formation of an antigen- antibody complex in regions 
of antigen or antibody excess may be studied by an observatior 
of the effect on the transmission of polarized light through 
such a system when a transverse electric field, normal to 
the direction of the light, is applied and removed. 
(See O'Konski, C. T. and Zimm, B. H., Science, 111, 113, (1950 ) ) 
1· In a given hemolytic re action, the effectiveness of the 
complement varies with the origin of the complement. This 
variation may be due to some specific reaction between the 
complement and the antibody. An investigation into the 
presence or absence of a complex which would result from 
such a reaction might assist in clarifying this feature of 
complement action. 
4. It has been su~gested that block ing anti-Rh antibodies 
are complexes of agglutinating antibodies with antigen sites 
-10.3-
which have b~en derived from destroyed Rh positive cells. 
(Itano, H. A. , Ph. D. Thesis , 1950) This may be checked by 
treating a blocking antiserum by a procedure which woul d 
dissociate such a complex and denature the antigen site, and 
then attempting to find a specific agglutinating action in 
the treated antiserum. 
i· Erythrocytes may be marked by a treatment with H2s, which 
converts the hemoglobin into sulfhemoglobin, and colors the 
cells a pale green. The immunologic action of such treated 
cells is.altered but little. (McKerns, K., and Denstedt, O., 
Can. J. Res. E27, 164, (1949 )l Use of these marked erythro-
cytes will permi t a demonstration of an exchange of specific 
antibodies from one erythrocyte to another. ( ~ayer, M. M. , 
Croft, C. C., Bowman, W. M., l!'ed. Proc. 9, 387, (1950}) 
6. '.rhe introduction of a radioactive atom into an antibody 
or antigen may result in an altered re activity of the anti-
body or antigen. The presence of such an effect should be 
investigated. 
7. The reaction between phenaceturic acid and acetic anhydride 
and sodium acetate yields 2-benzilidene-J-acetyl-5-oxazolone, 
and this product may be hydrolysed to yield N-acetyl glycine . 
(Shemyakin, M., Lur'e, S. I., Rodionovskaya, E. I., Q• A. !±J±, 
1096d.) This reaction should be investigated for its applica-
bility to the general case: 
R(2)-CO-NH-CH2-COOH 
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8. The anomalous reaction of benzyl magnesium chloride with 
certain reagents to yie l d o-tolyl derivatives instead of 
benzyl derivatives may be explained in terms of an inter-
molecular reaction, rather than an intramolecular rearrange-
ment. 
9. The accumulation of potassiwn ion in nerve and muscle 
fibres may be explained on the basis of a Donnan membrane 
equilibrium. (See Boyle, P. J., and Conway, E. J., J. Physiol., 
100, 1, (1942}} 
10. It has been stated that diving mammals such as whales do 
not suffer from nbends" because they make a complete expiration 
before diving. (Wiersma, c., personal communication) It is 
proposed that this situation arises, instead:, as a result of 
the fact that all inspirations are at atmospheric pressure, 
rather than at a higher pressure. 
